Development of Novel Ion Mobility-Mass Spectrometry Shift Reagents for Proteomic Applications by Kerr, Thomas Joshua
DEVELOPMENT OF NOVEL ION MOBILITY-MASS SPECTROMETRY SHIFT 
REAGENTS FOR PROTEOMIC APPLICATIONS 
By 
THOMAS J. KERR 
Dissertation 
Submitted to the Faculty of the  
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY 
in 
Chemistry 
May, 2011 
Nashville, Tennessee 
Approved: 
Professor John A. McLean 
Professor David E. Cliffel 
Professor Eva Harth 
Professor Chris Janetopoulos 
 
  
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my family, especially my parents, 
for their constant support 
 
 
 
 
 
 
 
 
 
iii 
ACKNOWLEDGEMENTS 
 I would like to thank Dr. John McLean and the entire McLean research group for 
their constant advice, help, suggestions, and encouragement. It was a great honor to be 
able to help get the research group started and work on some of the group’s first 
experiments involving peptide labeling. It was a great experience seeing the lab grow 
from a handful of students to its present size. 
 The members of my committee, Dr. David Cliffel, Dr. Eva Harth, and Dr. Chris 
Janetopoulos, have provided many tips and ideas concerning my research. I am 
especially grateful for the time and effort spent helping and encouraging me as I 
completed the requirements for my degree. 
 I also acknowledge the support of friends and family. They have supported me 
throughout my education experience, first to school at Wofford in South Carolina, and 
also through graduate school at Vanderbilt. Without their constant support, graduate 
school would have been much more difficult.    
 
 
 
 
 
 
 
iv 
TABLE OF CONTENTS 
 
Page 
DEDICATION .................................................................................................................... iii 
ACKNOWLEDGEMENTS ................................................................................................ iv 
LIST OF TABLES ............................................................................................................. vii 
LIST OF FIGURES .......................................................................................................... viii 
LIST OF ABBREVIATIONS ............................................................................................... x 
Chapter 
I. INTRODUCTION ............................................................................................................ 1 
               1.1. Mass spectrometry-based proteomics ........................................................ 1 
               1.2. Fundamentals of ion mobility-mass spectrometry ....................................... 7 
               1.3. Application of IM-MS to proteomics .......................................................... 12 
               1.4. Summary and objectives ........................................................................... 15 
II. RELATIVE QUANTITATION OF PEPTIDE FUNCTIONALITY USING METAL 
CHELATION LABELS ..................................................................................................... 21 
               2.1. Introduction ............................................................................................... 21 
               2.2. Experimental ............................................................................................. 27 
               2.3. Results and discussion ............................................................................. 30 
               2.4. Conclusions ............................................................................................... 34 
 
III. APPLICATION OF METAL CHELATION LABELS TO RELATIVE QUANTITATION 
OF PEPTIDES USING ION MOBILITY-MASS SPECTROMETRY ................................. 41 
               3.1. Introduction ............................................................................................... 41 
v 
               3.2. Experimental ............................................................................................. 42 
               3.3. Results and discussion ............................................................................. 45 
               3.4. Conclusions ............................................................................................... 54 
IV. MULITPLEXED ANALYSIS OF PEPTIDE FUNCTIONALITY USING METAL 
CHELATION LABELS ..................................................................................................... 59 
               4.1. Introduction ............................................................................................... 59 
               4.2. Experimental ............................................................................................. 60 
               4.3. Results and discussion ............................................................................. 66 
               4.4. Conclusions ............................................................................................... 71 
V. CONCLUSIONS AND FUTURE DIRECTIONS .......................................................... 77 
               5.1. Summary and conclusions ........................................................................ 77 
               5.2. Future directions ....................................................................................... 79 
Appendix 
A. THIOL TERMINATED SHIFT REAGENT SYNTHESIS PROGRESS ........................ 82 
B. MOUSE BRAIN TISSUE LABELING PROGRESS ..................................................... 97 
C. REFERENCES OF ADAPTATION FOR CHAPTERS .............................................. 107 
CURRICULUM VITAE ................................................................................................... 108 
 
 
 
 
 
 
vi 
LIST OF TABLES 
Table  Page 
2.1     List of lanthanide isotopes for metal selection purposes ....................................... 29 
2.2     Relative quantitation data for primary amine label ................................................ 32 
3.1     Collision cross sections of cysteine labeled peptides............................................ 51 
3.2     Collision cross sections for labeled and unlabeled lysozyme peptides ................. 54 
5.1     Comparison of stable isotope labeling methods ................................................... 80 
 
 
 
 
 
 
 
 
 
 
 
vii 
LIST OF FIGURES 
Figure Page 
1.1     Generalized ICAT relative quantitation workflow..................................................... 5 
1.2     Illustration of iTRAQ labels ...................................................................................... 6 
1.3     Schematic of a drift tube IM-MS instrument ............................................................ 8 
1.4     Schematic of a traveling wave IM-MS instrument ................................................. 10 
1.5     Illustration of the hard sphere model ..................................................................... 12 
1.6     Illustration of biomolecular correlation bands in IM-MS......................................... 14 
2.1     Representation of doubly labeled peptide relative quantitation ............................. 25 
2.2     Tandem MS spectrum (MALDI) of a labeled peptide ............................................ 26 
2.3     Tandem MS spectrum (ESI) of a labeled peptide ................................................. 27 
2.4     Illustration of relative quantitation for protein digests ............................................ 34 
2.5     Spectrum highlighting the importance of proper metal selection........................... 36 
2.6     Spectrum illustrating labeling a proteolyzed sample of multiple proteins .............. 37 
2.7     Representation of labeled peptide ionization efficiency ........................................ 39 
3.1     Illustration of the two types of shift reagents ......................................................... 47 
3.2     Illustration of collision cross section of labeled peptides ....................................... 48 
3.3     Comparision of collision cross section to lanthanide metal used .......................... 50 
viii 
3.4     Illustration of a labeled peptide and the peptide correlation band ......................... 52 
3.5     Illustration of a protein digest labeled at cysteine sites ......................................... 53 
3.6     A comparison of the data obtained in 1D and 2D MS ........................................... 56 
4.1     Representation of phosphopeptide labeling and MS/MS identification ................. 69 
4.2     Illustration of multiplex labeling of primary amine and cysteine ............................ 70 
4.3     Fragmentation curve for a labeled and unlabeled Ac-RYYRIK-NH2 ..................... 73 
4.4     Fragmentation curve for labeled and unlabeled Ac-YGGFMTSEKSQTPLVTL ..... 73 
4.5      Fragmentation curve for labeled and unlabeled SLRRSSCFGGR....................... 74 
5.1      Structure of proposed modular shift reagent label ............................................... 84 
A.1     Structure of proposed ionization enhancing shift reagent ..................................... 89 
A.2     Structure and MS/MS identification spectrum of intermediate 1 ........................... 92 
B.1     Unproteolyzed, unlabeled mouse brain IM-MS spectrum ................................... 104 
B.2     Trypsin in situ proteolyzed unlabeled mouse brain IM-MS spectrum ................. 105 
B.3     IM-MS spectrum of cysteine labeled mouse brain .............................................. 107 
 
 
 
 
ix 
 LIST OF ABBREVIATIONS 
AQUA            absolute quantitation 
CBZ              carboxybenzyl protecting group 
CCS              collision cross section 
CID                 collision induced dissociation 
CYC              horse cytochrome c 
Da                  Dalton 
DCM              dichloromethane 
DHB              2,5-dihydroxybenzoic acid 
DMF              dimethylformamide 
DOTA           1,4,7,10-tetra-azacyclododecane-N, N’, N’’, N’’’-tetraacetic acid 
DTIMS          drift tube ion mobility spectrometry 
DTT               dithiothreitol 
ECAT           element-coded affinity tags 
ESI                  electrospray ionization 
Fmoc              fluoronylmethyloxycarbonyl protecting group 
FMOC-Arg-OH  Fmoc protected arginine residue 
x 
HPLC             high performance liquid chromatography 
ICAT              isotope coded affinity tags 
iTRAQ          isobaric tags for relative and absolute quantitation 
IM-MS        ion mobility-mass spectrometry 
IMS                 ion mobility spectrometry 
Ln(III)             lanthanide metal  
LYSC             hen egg white Lysozyme  
MALDI            matrix assisted laser desorption/ionization  
MS                 mass spectrometry 
MSI                mass spectrometric imaging 
MS/MS          tandem mass spectrometry 
MYG            horse heart myoglobin 
m/z               mass to charge ratio 
NHS             N-hydroxysuccinimide 
NMR             nuclear magnetic resonance spectroscopy 
SATP            N-succinimidyl S-acetylthiopropionate 
TCEP             tris-2-carboxyethylphosphine  
TOF                time-of-flight 
xi 
xii 
TWIMS           traveling wave ion mobility spectrometry
CHAPTER I 
 
INTRODUCTION 
 
1.1 Mass spectrometry-based proteomics 
 Contemporary proteomics faces increasing challenges as analysis of samples of 
smaller sample size and lower abundance proteins is required. Since many biological 
processes are regulated by changing protein expression profiles, a great deal of current 
research focuses on the area of relative quantitation. Analysis of protein structure and 
sequence, including any post-translational modification (PTMs), enhances the 
understanding of the related biological processes. Mass spectrometry (MS) is well suited 
to address some of these challenges and the development of novel mass spectrometry-
based methods has led to a rapid increase in the knowledge generated from proteomic 
experiments. 
 A great deal of current proteomics research focuses on the quantitation of protein 
expression profiles, identification of PTMs, and the correlation of this information to the 
specific state of a biological system. Traditionally, separation and quantitation of proteins 
has been accomplished using 2D gel-based methods which require dyes, fluorophores, 
or radioactive labels. Typically proteins are separated on a gel, which is then stained 
using a dye (e.g. coomassie blue or silver stain) in order to visualize the proteins. 
Alternatively, radioactive labels may be covalently attached to proteins prior to gel 
separation. Subsequent to separation, protein spots are excised and quantified using a 
radiation counter.1 
 These methods can provide a general indication of protein relative abundance, 
however gel based methods also face several limitations. Low abundance proteins, for 
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example, are difficult to quantify using these methods. Further sample preparation can 
remove high abundance proteins, but low abundance proteins can still be hard to 
quantify. Furthermore, proteins of similar size and isoelectric point may overlap in the gel 
spot, leading to misidentification or overestimation of its quantity. Mass spectrometry-
based analysis offers several advantages over gel-based methods. 
 Contemporary MS-based methods for protein quantitation include stable isotope 
incorporation by enzymatic, metabolic, or covalent modification methods, in addition to 
label free methods. Stable isotope incorporation allows comparison of a number of 
control and experimental protein expression profiles while retaining similar structure, and 
thus ionization efficiency. Enzymatic labeling is accomplished by proteolysis of the 
protein in a solution of H218O, resulting in the incorporation of an 18O stable isotope in 
nearly every peptide. Comparison (using MS) of proteins digested normally and using 
H218O allows for relative quantitation of the protein expression profiles under 
experimental conditions.2-4 
18O labeling provides a relatively straightforward method of quantitation; however 
this method suffers from several limitations. The primary challenge of 18O labeling is the 
pH dependence which may result in the incorporation of multiple 18O isotopes in a single 
peptide. Multiple labeling splits peptide signal into several channels, impeding peak area 
analysis. Despite these challenges, 18O labeling provides a relatively low cost and easy 
method for the relative quantitation of peptides. Additionally, labeling may be optimized 
for peptide length by the use of different proteases.  
A similar method, which incorporates stable isotopes metabolically, is termed 
stable isotope labeling by amino acids in cell culture, or SILAC.5-6 The SILAC method is 
similar to 18O labeling in that a stable isotope is incorporated directly into the protein of 
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interest. In this case, cells are cultured in the presence of amino acids that have 
incorporated a heavy isotope, commonly 13C or 15N. Control cell samples are grown in 
normal amino acid media. By mixing purified and proteolyzed samples, relative protein 
expression profiles may be elucidated. The main limitations of SILAC are the time 
consuming need for cells to be cultured, and the requirement that samples be 
biologically viable. Clinical fluid samples that contain proteins, for example, cannot be 
analyzed by SILAC. 
Another method similar to SILAC is that of absolute quantitation (AQUA).7 The 
AQUA method of quantitation is similar to SILAC in that peptides incorporating heavy 
amino acids are used, however in AQUA recombinant peptides are used rather than 
peptides purified from cell culture. The use of recombinant isotopically heavy peptides 
removes the need for cell culture prior to experimental analysis and allows for 
quantitation of non-living samples such as clinical fluid samples. 
Typical AQUA experiments proceed by spiking in a known amount of an 
isotopically heavy synthesized peptide of the same sequence as the peptide of interest 
(including all PTMs). A comparison of the peak areas of the experimental peptide to the 
isotopically heavy peptide provides excellent absolute quantitation data since their 
ionization efficiencies are nearly identical. The main drawback of this method is that the 
sequence of the peptide of interest must be known a priori before quantitation 
experiments. Additionally, an isotopically heavy version of each peptide to be quantified 
must be synthesized. For small experiments (a couple of peptides) synthesis is not an 
issue, however it can quickly become cost prohibitive when considering a proteome wide 
quantitation experiment.  
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Incorporation of stable isotopes by covalent modification of peptides is another 
method of mass spectrometry-based protein quantitation. Isotope coded affinity tagging 
(ICAT)8 experiments proceed by the covalent addition of a label incorporating 2H or 13C 
isotopes or labels of natural isotopic abundance. For example, the isotopically heavy 
label may be used to modify proteins exposed to experimental conditions while the 
isotopically light label is used to modify proteins in the control sample. Labeled samples 
are then combined, proteolyzed, and analyzed by MS. Relative quantitation information 
is obtained by comparing the peak areas of the heavy versus light labeled peptides. 
Current ICAT methods rely on 13C isotopes to overcome the challenge of differing 
elution profiles of heavy versus light labeled peptides in liquid chromatography (LC) 
methods.9 The ICAT method (Figure 1.1) also offers the advantage of being able to 
analyze multiple experimental samples simultaneously, as opposed to the single 
experimental condition required by metabolic and enzymatic labeling. Traditional ICAT 
labels (such as Figure 1.1a) are limited to selective modification of the thiol group of 
cysteine, a relatively rare amino acid (ca. 3% of typical proteins in invertebrates) which 
some protein families lack altogether. However, an analogous label has been developed 
which provides ICAT like results with the modification of primary amine sites10 (i.e. the N-
terminus and lysine residues). Despite these improvements, the ICAT method still 
suffers from a limited number of simultaneous samples and a small (i.e. 8 Da), fixed 
mass shift, which can hamper the analysis of large peptides. 
An analogous method termed isobaric tags for relative and absolute quantitation 
(iTRAQ) offers similar data in a slightly different manner.11-12 Using iTRAQ, peptides are 
labeled with isobaric tags (Figure 1.2) that differ in the incorporation of stable isotopes 
(13C or 15N) in a diagnostic reporter fragment region, which may be cleaved by tandem  
4 
 Figure 1.1. A generalized scheme illustrating the ICAT method of relative quantitation. 
Proteins are covalently tagged at reduced thiol sites using the tag structure shown in (a). 
Locations marked with an X indicate sites of either hydrogen or deuterium incorporation. 
Current methods rely on the incorporation of 13C in the structure of the tag instead of 
deuterium. The progression of relative quantitation experiments is shown in (b). Adapted 
with permission from Nature Biotechnology, 1999, 17, 994-999. © (2003) Macmillan 
Magazines Ltd. 
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Figure 1.2. An illustration of iTRAQ isobaric tagging reagents used for the relative 
quantitation of peptides and proteins. (a) A schematic of the structure of the reporter 
region of the tag (113-121 m/z) which provides relative quantitation data following 
MS/MS analysis. Atoms indicated by X are either 12C or 13C. Atoms represented by Z 
bare either 14N or 15N. (b) An illustration of a complete iTRAQ tag which consists of the 
reporter region (left), a linker region to maintain the tags as isobaric (middle), and a 
chemically selective region for covalent modification of proteins and peptides (right). 
Adapted with permission from ref. 12. 
 
 
 
 
 
6 
MS (MS/MS) analysis. The different isobaric labels incorporate a mass balance region 
(not analyzed for relative quantitation data) that corrects for the different reporter 
fragment masses among the different tags. iTRAQ labels typically modify primary amine 
sites, thus labeling nearly every peptide after proteolysis. 
A typical iTRAQ experiment proceeds by proteolysis of the control and 
experimental samples. Each sample is then labeled at primary amine sites, each with a 
different iTRAQ reagent (i.e. a different reporter ion mass). Samples are subsequently 
mixed and analyzed by MS. Relative quantitation information on the peptides of interest 
is obtained by acquiring MS/MS data for each peptide. The peak areas of the reporter 
ions are compared to give the relative protein expression profile. iTRAQ suffers from 
several limitations, chiefly that in large scale proteomics experiments MS/MS information 
is typically only obtained on relatively high abundance peptides. Data dependent 
scanning often skips over low abundance peptides since fragmentation spectra typically 
have low signal. 
 
1.2 Fundamentals of Ion Mobility-Mass Spectrometry 
 
Ion mobility spectrometry (IMS) has been around in some form for over a 
century.21 It is important to note that IMS has been referred to by several names over the 
years, including plasma chromatography and ion chromatography. Early in the 
development of IMS, it was primarily used for applications in fundamental physics in the 
study of atomic ions.13 These experiments were typically attempts to elucidate atomic ion 
properties. Eventually, small molecules were also studied using IMS methods and near 
mid century analysis of larger molecules with applications in chemistry were becoming a 
possibility. 
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Figure 1.3 A schematic of the direct current (DC) drift tube IM-MS instrument used for 
collision cross section measurements. Ions are generated in the MALDI source and then 
travel through the drift tube where they are separated according to size. A differential 
skimming and pumping region allows for the high pressure differential between the drift 
cell (~ 4 Torr) and the TOF (~10-7 Torr). Ions are then pulsed orthogonally into the TOF 
for mass separation.32 
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In the 1960s, IMS was integrated with MS as a hyphenated method offering both 
size selection and mass identification through a TOF or quadrupole. The development of 
electrospray ionization (ESI) and matrix assisted laser desorption/ionization (MALDI) in 
the late 1980s and early 1990s made analysis of larger biologically relevant molecules a 
possibility.14 Early work on analysis of biomolecules using IM-MS paved the way for the 
more complex samples seen in the 2000s. Eventually complex samples, such as whole 
cell lysates, were analyzed using IM-MS.33 
Drift tube ion mobility instruments15 (Figure 1.3) consist of an ion source, an IMS 
drift cell, and a detector. Ions are generated in the source and are then directed into the 
IMS drift cell. The drift cell consists of a stacked set of conducting rings which have a low 
voltage gradient from front to back. The drift tube is also pressurized (usually 4-10 Torr) 
with a background buffer gas, commonly helium or some other non-reactive gas. Ions 
directed into the drift cell are pulled through the gas under the direction of a weak 
electrostatic field. As the ions traverse the drift cell they experience collisions with the 
buffer gas, slowing them down. Larger ions experience more collisions, thus larger ions 
exit the drift cell later than smaller ions.  
Another method of IMS termed traveling wave IMS (TWIMS)16 is used in the 
Waters Synapt G2 instrument (Figure 1.4). It operates in a similar fashion except that 
pulsed voltage waves guide the ions through the drift cell. That is, variable low voltage 
waves travel down the length of the drift cell. As these waves pass, ions are pushed 
along for a short distance before rolling over the top of the wave due to collisions with 
the buffer gas impeding ion progress. The size of the ion, and thus the number of 
collisions with the buffer gas, determine how readily ions are moved by the traveling  
 Figure 1.4. A schematic diagram of the MALDI-TWIM-TOFMS instrument (Waters Synapt G2 HDMS, Waters Corp., Manchester, 
UK). 
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waves. Larger ions experience more collisions with the buffer gas slowing them down so 
several wave passes are required to reach the end of the drift cell. Parameters such as 
the wave height (voltage) and velocity can be optimized to achieve excellent separation 
in the IM dimension. 
Subsequent to IM separation (whether by DTIMS or TWIMS), ions are pulsed 
orthogonally into a TOFMS for mass analysis. Since the time scale of mass analysis is 
much smaller than the time scale of IM separation (10s μs versus 10s ms, respectively) 
several mass spectra may be taken over the IM elution profile of a single drift cell 
injection. By taking multiple mass spectra for each IM elution profile and offsetting 
subsequent TOF extractions, two-dimensional IM-MS conformation space data may be 
obtained using a single detector. Interleaving in this manner allows for rapid separation 
and mass identification of molecules. 
Since DTIMS uses a steady, linear electrostatic gradient for separation of ions, it 
is possible to empirically measure the collision cross section of those ions. The kinetic 
theory of gasses17 and the hard sphere model18-19 (HSM, Figure 1.5) approximate the 
consequences of ion-neutral collisions in relation to collision cross section. The HSM 
treats the ion as a hard sphere that encounters elastic collisions with the buffer gas 
molecules where only momentum is transferred. Comparisons between HSM calculated 
cross sections and theoretical cross sections show that the hard sphere model is most 
relevant at masses greater than ca. 500, thus the HSM works well for peptide cross 
section analysis. Empirically determined cross sections may be calculated using 
equation 1, if the drift time, temperature, pressure of the buffer gas, mass of the ion, 
length of the drift cell, and the voltage gradient across the drift cell are known.17    
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Figure 1.5. A schematic illustrating the calculation of collision cross section. 
Experimenatlly, the collision cross section may be described as a circular area described 
by the radius of the ion and buffer gas combined, as shown above. 
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         Eq. 1.1 
 
The specific buffer gas used can have a dramatic effect on the quality of data 
obtained and different gasses have advantages and limitations.18 Helium is the preferred 
gas for collision cross section measurements since it is light, small, unreactive, and has 
a low polarizability. Gases with a higher polarizability will interact with ions longer, 
extending the drift time and reducing the applicability of the hard sphere model since ion-
neutral collision are no longer purely elastic. Other gasses such as argon, or methane, 
as well as changes in the electric field, may be used to optimize IM separation,20 
however helium and nitrogen are used exclusively in this work. 
 
1.3 Applications of IM-MS to proteomics 
 
The development of soft ionization sources (ESI and MALDI) led to increased 
interest in analysis of biomolecules by mass spectrometric methods.21-24 The mating of 
IMS and MS enhanced the data collected from analysis of biological samples. Initially, 
research focused on peptides, but was expanded to analysis of intact proteins by the 
late 1990s and early 2000s. During this time it was discovered that biomolecules tend to 
separate based on class (e.g. lipid versus peptide) in IM-MS data, commonly referred to 
as conformation space.25-26 Further research outline the boundary of an area specific to 
peptides, the peptide correlation band. This work illustrated that 99% of peptide signals 
fall within ±10% of the midline of this correlation band.27 While ion mobility separations  
13 
  
Figure 1.6. A graphical representation of the area different classes occupy in IM-MS 
conformation space. Note that peptides occupy a relatively narrow band of conformation 
space and are separated from both lipids and carbohydrates. Adapted with permission 
from ref. 31. 
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are possible using either ion source, MALDI was preferred for this work due to its 
production of singly charged ions nearly exclusively, as well as for its tolerance of salts. 
Further analysis showed that each class of biomolecule occupies a specific area 
of conformation space under a given set of experimental conditions (Figure 1.6). Thus, 
signals from different classes of biomolecules may be separated in two-dimensional  
space. This separation by class is due to the gas phase packing efficiency of these 
molecules which increases in the order lipids < peptides < carbohydrates < 
oligonucleotides.21 Structural information about a specific signal may be inferred from its 
specific location within the correlation band. For example, phosphopeptides tend to 
appear in the lower portions of the peptide correlation band;28 however a signal’s 
location within the correlation band should not be used for confident assignment of 
signals. Further analysis, by MS/MS for example, should be completed to obtain 
confident identification information. 
The IM-MS separation dimensions are highly correlated, as opposed to highly 
orthogonal separation dimensions such as isoelectric focusing and gel electrophoresis in 
2D gel methods. Dimensional analysis indicates that mass and collision cross section 
are related since biomolecules are made up of a limited number of different elements 
(i.e. C, H, O, P, S, and N).13 Thus, biopolymer mass scales as mass (or length) cubed. 
Surface area (collision cross section, the IM dimension) scales as length squared. This 
correlation gives biomolecular correlation bands a curved appearance. 
 Since the biomolecular correlation bands are fairly narrow (±10% from the 
midline)27 it is possible to shift specific signals out of their correlation band into an area 
that is not predicted to contain signals of that particular biomolecular class. Due to the 
curved nature of the correlation bands, it is readily apparent that there are two options 
15 
for the direction of shift. Low density molecules that have high collision cross section 
compared to mass have been studied previously.29-30 Molecules such as crown ethers, 
dendrimers, or polymer based reagents will shift specific signals to an area above the 
correlation band. Furthermore, the crown ether shift reagents29 are non-covalent, 
allowing for dissociation prior to MS detection in order to retain the original peptide 
mass. 
 A second option is using high density reagents that have a low collision cross 
section (compared to mass) to shift specific signals to an area below the correlation 
band. Development of high density, lanthanide-based shift reagents are discussed in this 
report. 
 
1.4 Summary and objectives 
 
 For my dissertation research, I aimed to develop and explore the application of 
novel ion mobility shift reagents for proteomic applications. These shift reagents were 
envisioned to provide a rapid method for screening complex proteomic samples for 
specific peptide functionalities. In addition, labels would be able to provide both a frame 
of reference for tandem MS sequence identification, as well as a method of relative 
quantitation of peptides and proteins. Toward this goal, cysteine and primary amine 
specific shift reagent applications were explored for their potential in aiding the confident 
identification of peptide signals. These shift reagents do indeed show great utility in the 
relative quantitation of peptide samples in both one and two dimensional MS methods. 
Further development of the shift reagent labeling method included exploration of their 
utility for in situ labeling of tissue sections.  Some specific milestones and the chapter in 
which each is discussed follows: 
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1. Do lanthanide based shift reagents provide an acceptable method of the relative 
quantitation of peptides? Does the high degree of flexibility of these reagents 
offer advantages over less flexible quantitation reagents? Do these labels 
dissociate under CID conditions? This is addressed in Chapter 2: relative 
quantitation of peptide functionality using metal chelation labels. 
2. Do lanthanide based shift reagents offer a useful degree of shift from the 
established peptide correlation band? Is this shift significant enough to avoid 
confusion between labeled and unlabeled peptide signals? This is addressed in 
Chapter 3: application of metal chelation labels to relative quantitation of peptides 
using ion mobility-mass spectrometry. 
3. Do these shift reagent labels offer a reasonable method for the relative 
quantitation of proteins? Do these labels provide a reasonable method for the 
relative quantitation of a proteolyzed mixture of several proteins? How does this 
compare with current methods of relative quantitation? This is addressed in 
Chapter 2: Relative Quantitation of Peptide Functionality Using Metal Chelation 
Labels. 
4.  Is it possible to do multiplex labeling of multiple functionalities on a single 
peptide? Does the use of a different lanthanide for each functionality offer 
advantages or aid in sequence assignment? This is addressed in Chapter 4: 
Multiplexed Analysis of Peptide Functionality Using Metal Chelation Labels. 
The primary goal of this dissertation research was to develop novel IM-MS shift 
reagents to allow rapid identification of specific peptide functionalities in conformation 
space. This was achieved using lanthanide coordinating labels. Initial proof of concept 
experiments using pure peptides indicated that the lanthanide-based labels provided a 
17 
significant amount of shift from the peptide correlation band. From there, the project was 
expanded to include relative quantitation of pure peptides, labeling of complex mixtures 
(simulated by tryptic protein digests), relative quantitation of protein digests, relative 
quantitation of proteolyzed mixtures of proteins, and multiplex labeling of different 
functionality (i.e. both the cysteine side chain and primary amines) on the same peptide 
using different lanthanide metals. In addition, both in situ labeling of mouse brain tissue 
sections and the development of an ionization enhancing label for use in tagging 
phosphopeptides were explored. Description of these two areas are described in 
Appendix A and B.  
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CHAPTER II 
 
RELATIVE QUANTITATION OF PEPTIDE FUNCTIONALITY USING METAL 
CHELATION LABELS 
 
2.1 INTRODUCTION 
 
 Mass spectrometry based relative quantitation of protein expression profiles has 
experienced a recent period of rapid growth as new instrumental technologies and 
labeling strategies have been developed.1 New advances in labeling methods,1-3 and 
label free methods,4-6 have changed the way in which the relative quantitation of protein 
expression profiles using multiple samples is obtained. Many labeling methods, such as 
SILAC1 and ICAT2 use isotope enrichment of one sample versus another to maintain the 
chemical composition of the peptide for uniform ionization efficiency in the ratioing of 
peak areas for relative quantitation. However, the number of experimental conditions 
that can be analyzed by these methods is limited to typically less than 4 by the nominal 
isotopic shifts afforded by isotopic enrichment of 13C, 15N, and 2H. 
 More recently, element coded affinity tags (ECAT) have been described for the 
relative quantitation of peptides.7-9 ECAT is analogous to ICAT in that relative 
quantitation information is obtained based on the comparative ratio between an 
isotopically heavy and light label, respectively, however the source of the isotopic shift is 
incorporation of different lanthanide (Ln) metal atoms. ECAT labels are similar to that 
shown in scheme 2.1, whereby a Ln(III) ion is chelated and is subsequently covalently 
attached at cysteine sulfhydryl groups via reaction with a maleimido moiety. 
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Scheme 2.1. 
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 The ionic radii of Ln(III) ions are nearly invariant across the series of metals (ca. 
87-117 pm), which in turn results in minor differences of otherwise very strong stability 
constants (typical stability constant, log(K), values of 20-24).10 The stability of such 
labels is underscored by their use as common MRI contrast enhancing agents.11 For MS 
labeling purposes, the ability to select different Ln(III) ions for labeling different 
experimental conditions allows isotopic shifts of up to 36 Da and can accommodate the 
simultaneous relative quantitation of experimental samples limited only by the number of 
lanthanides or isotopically enriched lanthanides used. 
 In contrast with studies using ECAT for the labeling of cysteine residues (via 
sulfhydryl derivatization),7-9 the present studies utilizing primary amine derivatization 
offer three important advantages, Firstly, unless the N-terminus is modified, nearly all 
peptides will incorporate at least one label. Secondly, labeling at a pH approximately the 
same as the pKa of the side chain of lysine (~11.1) results in multiple labeling of the 
peptide (Figure 2.1). The latter has particular significance when utilizing trypsin 
proteolysis, because this results in peptides either containing a single label (R-
terminated) or two labels (K-terminated) for facile assignments. This is also significant 
from the standpoint of MS/MS sequencing of peptides because the label(s) only reside 
at the N-terminus or at both termini, which provides a frame of reference for assigning 
fragment ion peaks. Similar to previous reports, the ECAT labels described here remain 
intact through collision induced dissociation (CID) processes using both MALDI (Figure 
2.2) and ESI (Figure 2.3) ion sources.7-9 Thirdly, primary amine labeling can be 
combined with sulfhydryl labeling using different metals for each (Chapter 4) to enhance 
the information content for specific peptides. Similar to ICAT strategies, the ratio of the 
integrated isotope cluster of the peptide corresponding to heavy and light labeling is 
compared. 
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Figure 2.1. Typical spectra in relative quantitation via primary amine labeling. Top, 
middle, and bottom correspond to expanded mass spectra about the peptide 
MEHFRWGK labeled with Tb and Ho in ratios of 3:1, 1:1, and 1:3, respectively. The 
peptide is labeled both at the N-terminus and the C-terminal Lys residue resulting in a 12 
Da mass shift. 
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Figure 2.2. Tandem MS spectrum (generated using a MALDI ion source) of a peptide 
(HGTVVLTALGGILK) from a tryptic myoglobin digest labeled with the primary amine 
specific shift reagents. The peptide sequence is shown above with an asterisk (*) 
marking the location of tag addition (i.e. at the N-terminus and the Lys residue). Labeled 
b and y ion peaks correspond to the fragment mass including the additional mass of the 
label since both termini are labeled. 
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Figure 2.3. Tandem MS spectrum (generated suing an ESI ion source) of bradykinin 
(RPPGFSPFR) labeled with the primary amine specific shift reagent. The peptide 
sequence is shown above with an asterisk (*) marking the location of tag addition. 
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2.2 Experimental 
 
 The specific labels used in this work consist of a metal chelation moiety, a linker 
region that acts as a spacer between the chelation center and the reactive target, and a 
primary amine reactive N-hydroxysuccinimide (NHS) ester group (shown in Scheme 1). 
The metal chelation moiety is based on 1,4,7,10-tetra-azacyclododecane-N, N’, N’’, N’’’-
tetraacetic acid (DOTA) obtained from Macrocyclics (Dallas, TX). The lanthanides used 
in this work include La, Lu, Tm, Ho, and Tb, which were purchased from Strem 
(Newburyport, MA) or Sigma (St. Louis, MO) as chloride hydrate salts. These 
lanthanides were selected because of their mass differences and because they are (Tb, 
Ho, and Tm) or are nearly (La and Lu), monoisotopic (Table 2.1). Covalent labeling of 
individual peptides and those generated from tryptic proteolysis of proteins was 
performed in a two-step reaction as depicted in Scheme 1. 
Briefly, the first step involves the addition of the NHS-DOTA label to primary 
amine sites on the peptide (i.e. at the N-terminus and any Lys residues) at room 
temperature and pH 10. This is followed by chelating the chosen Ln(III) metal to the tag 
by heating the tagged sample in the presence of 10 equivalents of lanthanide metal at 
pH 5.6, which was optimized based on a previously published protocol.12 Following 
labeling, the labeled peptides are stable over a wide pH range (3-10 investigated thus 
far), however after spotting onto a MALDI target, small amounts of degradation products 
may be observed after ca. 5 hours. 
Proteolysis of common proteins was used to generate a mixture of peptides for 
labeling. Initially, proteins were denatured at 90˚C and any disulfide bonds were reduced 
using an appropriate reducing agent.13 For this dissertation tris-2-carboxyethylphosphine 
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 La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu 
136 - 0.2 - - - - - - - - - - - - - 
138 0.1 0.3 - - - - - - - - - - - - - 
139 99.9 - - - - - - - - - - - - - - 
140 - 88.5 - - - - - - - - - - - - - 
141 - tr 100 - - - - - - - - - - - - 
142 - 11.1 - 27.2 - - - - - - - - - - - 
143 - - - 12.2 - - - - - - - - - - - 
144 - tr - 23.8 - 3.1 - - - - - - - - - 
145 - - - 8.3 - - - - - - - - - - - 
146 - - - 17.2 - - - - - - - - - - - 
147 - - - - - 15.0 - - - - - - - - - 
148 - - - 5.7 - 11.2 - - - - - - - - - 
149 - - - - - 13.9 - - - - - - - - - 
150 - - - 5.6 - 7.4 - - - - - - - - - 
151 - - - - - - 47.8 - - - - - - - - 
152 - - - - - 26.8 - 0.2 - - - - - - - 
153 - - - - - - 52.2 - - - - - - - - 
154 - - - - - 22.8 - 2.2 - - - - - - - 
155 - - - - - - - 14.8 - - - - - - - 
156 - - - - - - - 20.5 - tr - - - - - 
157 - - - - - - - 15.7 - - - - - - - 
158 - - - - - - - 24.8 - 0.1 - - - - - 
159 - - - - - - - - 100 - - - - - - 
160 - - - - - - - 21.9 - 2.3 - - - - - 
161 - - - - - - - - - 18.9 - - - - - 
162 - - - - - - - - - 25.5 - 0.1 - - - 
163 - - - - - - - - - 24.9 - - - - - 
164 - - - - - - - - - 28.3 - 1.6 - - - 
165 - - - - - - - - - - 100 - - - - 
166 - - - - - - - - - - - 33.5 - - - 
167 - - - - - - - - - - - 22.9 - - - 
168 - - - - - - - - - - - 27.0 - 0.1 - 
169 - - - - - - - - - - - - 100 tr - 
170 - - - - - - - - - - - 14.9 - 3.0 - 
171 - - - - - - - - - - - - - 14.3 - 
172 - - - - - - - - - - - - - 21.8 - 
173 - - - - - - - - - - - - - 16.1 - 
174 - - - - - - - - - - - - - 31.8 - 
175 - - - - - - - - - - - - - - 97.4 
176 - - - - - - - - - - - - - 12.8 2.6 
Table 2.1. Table of lanthanide isotopes and relative abundance values useful for 
selection of the metal for incorporation in the shift reagent tag. 
29 
 (TCEP) was used more frequently than dithiothreitol (DTT) to limit quenching 
and side reactions when labeling using the maleimido label. Upon cooling to room 
temperature, trypsin was added in a 1:40 w/w ratio at a pH of approximately 8. This 
reaction is then heated at 37˚C overnight (18-24 hours). The resulting peptides are then 
desalted prior to labeling and analysis. 
A more complex mixture was simulated by proteolyzing multiple proteins in a 
one-pot reaction. Three proteins, hen egg white Lysozyme, horse cytochrome c, and 
horse heart Myoglobin, were mixed in an equimolar ratio in 60mM ammonium 
bicarbonate buffer of pH ~8. TCEP reducing agent was added to cleave the disulfide 
bonds in Lysozyme, and the protein mixture was denatured at 90˚C for 20 minutes. After 
cooling to room temperature, an appropriate amount of trypsin (a 1:40 ratio by mass) 
was added and proteolysis was allowed to proceed for 18-24 hours. After digestion, the 
resulting peptides were desalted using C18 spin columns. These peptides were then 
either analyzed using MALDI TOFMS or labeled according to Scheme 2.1. 
 The change in ionization efficiency of peptide upon labeling was also explored. A 
series of peptides based on of the sequence of bradykinin (RPPGFSPFR) were 
synthesized (Genscript) whereby one or both arginines were replaced with an aspartic 
acid residue. An equimolar aliquot of each of these three peptides was mixed and 
analyzed using an Applied Biosystems DE STR TOFMS. The peak areas of each 
peptide were compared. Subsequently, these same three peptides were labeled under 
the same reaction conditions in an equimolar ratio and analyzed using the same 
instrument. The peak area distribution of labeled versus unlabeled were compared to 
determine the effect of the lanthanide label on the ionization efficiency of the peptide. 
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2.3 Results and discussion 
 
Several proof of concept peptides were chosen (Table 2.2) for simulated relative 
quantitation experiments. After labeling, the ratio of the monoisotopic peak areas of the 
tagged species was compared to the theoretical ratio for each experiment. A wide range 
of theoretical quantitation ratios were analyzed. Percent error for model peptides was 
generally below 15% with the lowest percent errors occurring near a theoretical ratio of 
0.5 (Table 2.2). As the ratio decreases below 0.5, more error between the expected 
value and the experimental value arises. Therefore, samples of extremely different 
concentration may require dilution of the high abundance sample so the experimental 
ratio will be 0.5-1 for the most accurate results. The wide variety of metals and  peptide 
masses used illustrates that the particular metal system chosen does not affect the 
accuracy of the relative quantitation measurement.  
Relative quantitation of a complex mixture was simulated by tagging tryptic 
peptides from horse heart Myoglobin and horse cytochrome c. Figure 2.4a represents 
relative quantitation using cytochrome c. It is important to note that singly labeled 
peptides exhibit a 6 Da shift, while doubly labeled peptides show a 12 Da shift due to the 
addition of an extra label. The ratio of the monoisotopic peak areas for each peptide pair 
was compared to the theoretical ratio of 0.5. The average ratio of all Myoglobin peptides 
analyzed agrees very well with the expected ratio of 0.5. Tryptic Myoglobin peptides 
were labeled using the primary amine specific ECAT like reagent according to Scheme  
2.1. The tagged peptides were desalted, mixed, and spotted on a MALDI target plate for 
analysis (Figure 2.4b). 
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Table 2.2. Relative quantitation data for primary amine tagging. 
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The ECAT labeling method can also provide primary structural information in 
addition to relative quantitation information. Structural information can be obtained in the 
same experiment as relative quantitation data or in a standalone experiment. Figure 2.4b 
illustrates a relative quantitation experiment on a trypsin digest of horse heart Myoglobin. 
The metal system chosen, (Ho/Tb) results in an isotopic shift of 6 Daltons for a singly 
labeled peptide.  
Lysozyme provides an interesting illustration where metal system selection and 
flexibility  becomes important to the success of the experiment. Two Lysozyme peptides, 
GYSLGNWVCAAK and CKGTDVQAWIR (1269.5 and 1277.5 m/z, respectively), are 
separated by ca. 8 Daltons. Using the Ho/Tb metal system used for Myoglobin (a 6 
Dalton shift) results in an overlap of the isotope profiles of the two labeled species. 
Changing the metal system to Tm/Tb (a 10 Dalton shift) greatly reduces spectral 
overlap. Changing the metal system again to Lu/Tb (a 16 Dalton shift) separates the 
peaks even further resulting in complete resolution as illustrated in Figure 2.5. 
Labeling of complex mixtures is an important step toward a labeling method becoming 
more useful. Current proteomics problems are usually studied in a relatively complex 
state. These complex samples may contain many proteins that must be proteolyzed and 
labeled for either identification in 2D IM-MS conformation space, or for purposes of 
relative quantitation using one dimensional MALDI TOFMS. Complex samples consisting 
of three proteins (horse heart Myoglobin, horse cytochrome c, and intensity peptides 
were identified, however they are not labeled due to space constraints. Panel b in Figure 
2.6 illustrates the MALDI TOFMS spectrum of this complex tryptic digest labeled with a 
primary amine specific shift reagent coordinated to terbium. The same high intensity 
peaks from panel a are labeled in panel b. 
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Figure 2.4. (a) An illustration of the mass shift for singly and doubly labeled peptides in a 
tryptic cytochrome c digestion relative quantitation experiment with a theoretical ratio of 
0.5. TGPNLHGLFGR was tagged once (N-terminus) using the Ho/Tb metal system 
showing a 6 Dalton shift. MIFAGIK was tagged twice (N-terminus and Lys residue) and 
shows a 12 Dalton shift. (b) A typical spectrum illustrating a relative quantitation (0.5 
theoretical ratio) experiment using horse heart Myoglobin and the Ho/Tb metal system. 
Inset zooms in on two pairs of peaks showing singly versus doubly tagged species. 
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The ionization efficiency of labeled peptides and unlabeled peptides were 
compared using a simple ratio.14-15 Briefly, the peak area associated with each peptide 
sequence was divided into the total peak area of all three peptides. A plot of this data is 
show in Figure 2.7.  As indicated in panel A (as well as a close up with error bars in 
panel B), both labeled and unlabeled peptides show similar ionization profiles.  
In addition, peptides labeled with different lanthanide metals also show very little 
deviation. This small deviation supports the conclusion that the lanthanide labels do not 
significantly affect the relative ionization efficiency of peptides (shown in Figure 2.7, 
panel b) and thus are useful for relative quantitation purposes. Widely differing ionization 
profiles when using different metals would complicate relative quantitation experiments 
and introduce more error into the analysis.  
The ECAT method of obtaining relative quantitation data works well for both 
simple and more complex peptide systems. The ECAT method works best when there is 
less than a three-fold difference in concentration between the peptides of interest since 
the percent error increases as the difference in concentration increases. This effect is 
likely due to ion suppression effects in the source of the mass spectrometer resulting 
from the low concentration peptide competing with the high concentration peptide for 
ionization. 
2.4 Conclusion 
 
The relative quantitation of peptides and proteins is an integral part of proteomics 
research. As sample complexity has increased and lower abundance proteins are 
studied, novel methods of analysis must be developed. Lanthanide based relative 
quantitation reagents offer several advantages over other stable isotope methods  
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Figure 2.5. An illustration of the optimal metal system being dictated by the specific 
sample. In this experiment, a hen egg white Lysozyme digestion was tagged using a 
cysteine specific shift reagent and the various metal systems in a theoretical ratio of 2:1. 
Panel A shows the Tb/Ho metal system (a 6 Dalton shift) where two peaks overlap, 
causing error in the relative quantitation. Panel B illustrates use of the Tb/Tm metal 
system (a 10 Dalton shift) on the same sample. The labeled peaks are still not well 
resolved. Panel C shows the Tb/Lu metal system (a 16 Dalton shift). The labeled peaks 
are completely resolved, allowing for more accurate relative quantitation results.  
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Figure 2.6. An illustration of a complex proteolysis experiment in which horse heart 
Myoglobin, horse cytochrome c, and hen egg white Lysozyme were digested 
simultaneously. Panel A illustrates the analysis and identification of unlabeled peptides. 
The sequence and source (in parentheses, Myoglobin:MYG, cytochrome c:CYC, 
Lysozyme:LYSC). Panel B shows the analysis of the same sample of proteolyzed 
peptides labeled with a primary amine specific shift reagent that coordinated terbium. 
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currently available, namely greater flexibility in the selection of the mass shift between 
labeled peptide species. This flexibility offers quantitative methods to systems that 
require a different amount of mass shift, such as Lysozyme. The primary amine specific 
shift reagents shown in this chapter are preferred for relative quantitation purposes since 
nearly every peptide in a proteolysis experiment will be labeled. The cysteine specific 
shift reagent will allow for quantitation, however since the relative frequency of cysteine 
is lower than the frequency of primary amines, every peptide may not receive a label. 
Importantly for relative quantitation experiments, the relative ionization efficiencies of 
different lanthanide metals in incorporated in the label are nearly identical. Thus, when 
different metals are used, these ECAT like reagents offer the ability to obtain excellent 
relative quantitation data on complex peptide samples. 
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Figure 2.7. A graphical representation of the relative ionization efficiency of a series of 
peptides related to bradykinin (RPPGFSPFR). Two additional peptides were synthesized 
whereby one or both arginine residues in bradykinin was replaced with aspartic acid, 
creating a more acidic peptide. Panel A shows the peak areas of each peptide relative to 
the combined peak areas of the three peptides. As expected peptides with more basic 
residues showed better ionization, due to increased gas phase basicity. Panel B 
illustrates the two more basic peptides (including error bars) showing a significant 
difference in ionization between the two peptides, however, there is not a significant 
difference in ionization between the same peptide labeled with different lanthanide 
metals. 
 
 
39 
References 
 
1. Aebersold, R.; Mann, M., “Mass spectrometry-based Proteomics.” Nature 2003, 422, 
198-207. 
2. Gygi, S.P.; Rist, B.; Gerber, S.A.; Turecek, F.; Gelb, M.H.; Aebersold, R. 
“Quantitative Analysis of Complex Protein Mixtures Using Isotope-Coded Affinity 
Tags.” Nat. Biotech. 1999, 17, 994-999. 
3. Gerber, S.A.; Rush, J.; Stemman, O.; Kirschner, M.W.; Gygi S.P. “Absolute 
Quantification of Proteins and Phosphoproteins from Cell Lysates by Tandem MS.” 
Proc. Nat. Acad. Sci. USA 2003, 100, 6940-6945. 
4. Chelius, D.; Bondarenko, P.V. “Quantitative Profiling of Proteins in Complex Mixtures 
Using Liquid Chromatography and Mass Spectrometry.” J. Proteome Res. 2002, 1, 
317-323. 
5. Steen, H.; Jebanathirajah, J.A.; Springer, M.; Kirschner, M.W. “Stable Isotope-free 
Relative and Absolute Quantitation of Protein Phosphorylation Stoichiometry by MS.” 
Proc. Nat. Acad. Sci. USA 2005, 102, 3948-3953. 
6. Old, W.M.; Meyer-Arendt, K.; Aveline-Wolf, L.; Pierce, K.G.; Mendoza, A.; Sevinsky, 
J.R.; Resing, K.A.; Ahn, N.G. “Comparison of Label-free Methods for Quantifying 
Human Proteins by Shotgun Proteomics.” Moll. Cell. Proteom. 2005, 47, 1487-1502. 
7. Whetstone, P.A.; Butlin, N.G.; Corneillie, T.M.; Meares, C.F. “Element-coded Affinity 
Tags for Peptides and Proteins.” Bioconj. Chem. 2004, 15, 3-6. 
8. Liu, H.; Zhang, Y.; Wang, J.; Wang, D.; Zhou, C.; Cai, Y.; Qian, X. “Method for 
Quantitative Proteomics Research by Using Metal Element Chelated Tags Coupled 
with Mass Spectrometry.” Anal. Chem. 2006, 78, 6614-6621. 
9. Ahrends, R.; Pieper, S.; Kühn, A.; Weisshoff, H.; Hamester, M.; Lindemann, T.; 
Scheler, C.; Lehmann, K.; Taubner, K.; Linscheid, M.W. “A Metal-coded Affinity Tag 
Approach to Quantitative Proteomics.” Moll. Cell. Proteom. 2007, 6, 1907-1916. 
10. Tóth, E.; Brücher, E. “Stability Constants of the Lanthanide (III)-1,4,7,10-
tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetate Complexes.” Inorg. Chim. Acta 
1994, 221, 165-167. 
11. Caravan, P. “Strategies for Increasing the Sensitivity of Gadolinium-based MRI 
Contrast Agents.” Chem. Soc. Rev. 2006, 35, 512-523. 
12. Zhu, X.; Lever, S.Z. “Formation Kinetics and Stability Studies on the Lanthanide 
Complexes of 1,4,7,10-tetra-azacyclododecane-N,N’,N’’,N’’’-tetraacetic acid by 
Capillary Electrophoresis.” Electrophoresis. 2002, 23, 1348-1356. 
13. Park, Z.Y.; Russell, D.H. “Thermal Denaturation: A Useful Technique in Peptide 
Mass Mapping.” Anal. Chem. 2000, 72,2667-2670. 
40 
14. Grey, A.; Hoeger, C.A.; Miller, C.L.; Goedken, T.; Rivier, J.E.; Fischer, W.H. 
“Monitoring Protein Kinase and Phosphatase Reactions with Matrix-assisted Laser 
Desorption/Ionization Mass Spectrometry and Capillary Zone Electrophoresis: 
Comparison of the Detection Efficiency of Peptide-Phosphopeptide Mixtures.” 
Biological Mass Spectrom. 1994, 23, 519-528. 
15. Dekker, L.J.; Dalebout, J.C.; Siccama, I.; Jenster, G.; Smitt, P.A.S.; Luider, T.M. “A 
New Method to Analyze Matrix-assisted Laser Desorption/Ionization Time-of-flight 
Peptide Profiling Mass Spectra.” Rapid Comm. Mass Spectrom. 2005, 19, 865-870. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
CHAPTER III 
 
APPLICATION OF METAL CHELATION LABELS TO RELATIVE QUANTITATION OF 
PEPTIDES USING ION MOBILITY-MASS SPECTROMETRY 
 
3.1Introduction 
 
IMS has proven to be a useful analytical tool for the detection of suspected 
drugs, chemical warfare agents, and explosives.1-2 When IMS is combined with mass 
spectrometry (IM-MS) it becomes a useful tool for the rapid analysis of complex 
biological samples.3 IM-MS provides a rapid alternative separation technique in that 
separations are performed over the course of 100s of μs to ms, compared to the minutes 
to hours time scale common to LC-based methods. IM-MS based methods also provide 
several other advantages: (i) mitigation of ion suppression effects, (ii) less complicated 
MS spectra facilitate peak identification, and (iii) analyte signals occur separate from 
chemical noise.  
Ion mobility shift reagents allow specific signals (based on chemical functionality) 
to be isolated from signals of the same class of biomolecule (e.g. lipid or peptide) that do 
not contain that specific functionality. IM-MS shift reagents offer enhanced separation in 
the IM dimension by significantly altering the gas phase packing efficiency of the ion. 
Both crown ethers,4 and PEG-based shift reagents5 have been previously studied and 
offer robust methods for the isolation of signals in IM-MS conformation space. 
The crown ether and PEG-based shift reagents (studied by the Clemmer and 
Creaser groups, respectively) function by greatly increasing the collision cross section of 
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the labeled ion while increasing mass to a much smaller extent. This represents a 
decrease of the gas phase packing efficiency when compared to unlabeled ions of the 
same mass. These are termed low density shift reagents since the labeled peptides are 
shifted to an area above (longer drift times) the peptide correlation band. An interesting 
property of the crown ether shift reagents is that labeling is a result of non-covalent 
interaction with basic sites on the peptide.4 Thus, the shift reagent may be removed by 
collisional activation after elution from the drift cell so that the parent peptide mass is 
retained. This chapter focuses on high density shift reagents and their application to 
isolating specific peptide signals in an area representing a smaller collision cross section 
than is predicted by the same mass in the peptide correlation band. 
 
3.2 Experimental 
 
All model peptides were purchased from American Peptide Company 
(Sunnyvale,CA) or Anaspec (San Jose, CA). Proteins were purchased from Sigma (St. 
Louis, MO). Lanthanide chelating labels were purchased from Macrocyclics (Dallas, TX). 
Lanthanide metals (La, Tb, Ho, Tm, and Lu) were purchased as LnCl3 hydrates from 
Strem chemicals for Research (Newburyport, MA). Solvents were also purchased from 
Sigma and all reagents were used without further purification.  
Several cysteine-containing peptides and proteins were chosen for proof-of-
concept experiments. These peptides were chosen in order to provide a range of mass 
(ca. 700-1900 Da) and cysteine location within the peptide sequence. Model peptides 
were labeled at cysteine residues using a label based on 1,4,7,10-tetra-
azacyclododecane-N, N’, N’’, N’’’-tetraacetic acid (DOTA) as shown in Scheme 3.1.  
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Scheme 3.1. An illustration of the labeling reaction for specific modification of cysteine 
residues using an IM-MS shift reagent. 
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Lanthanide metal atoms were coordinated (prior to labeling) according to a method 
adapted from Zhu and Lever.6 Briefly, the cysteine specific label and lanthanide metal (in 
a 1:50 ratio) were heated at 80˚C for 30 minutes at a pH of 5.7. Subsequent to metal 
incorporation, the free thiols of cysteine residues were modified by the maleimide 
functionality of the label (a 1:20 thiol:label ratio) at room temperature for three hours at a 
pH of 5.7. After modification, labeled peptides were desalted using Ziptips (Millipore) and 
analyzed using a custom IM-MS instrument (illustrated in Figure 1.3). 
 Similarly, primary amine sites were labeled using a shift reagent that has a N-
hydroxysuccinimide reactive moiety. Briefly, labeling progressed by mixing the primary 
amine specific label and peptide (in a 20:1 ratio) in borate buffered solution of pH 10. 
Subsequent to primary amine modification, a lanthanide metal was incorporated by 
adding lanthanide (in a 50:1 ratio) to the labeled peptide at an acetate buffered pH of 
5.7. The solution was heated at 80˚C for 30 minutes. Labeled peptides were desalted 
using ziptips (Millipore) prior to analysis. 
Complex samples were simulated by peptide mixtures derived from proteolysis of 
model proteins. Hen egg white Lysozyme was chosen since it provided a mixture of 
several cysteine-containing peptides in addition to many cysteine free peptides. 
Lysozyme was proteolyzed as described elsewhere.7 Briefly, disulfide bonds were 
reduced using tris (2-carboxyethyl) phsophine (TCEP) and the protein was heat 
denatured at 90˚C for 20 minutes prior to digestion. An appropriate amount of trypsin 
(1:40 trypsin:protein by mass) was added and allowed to digest the protein at 37˚C and 
pH 8 for 18-24 hours. Subsequent to digestion, the resulting peptides were desalted 
using C18 spin columns (Pierce) and peptide labeling proceeded as described in 
Scheme 3.1. Labeled protein digests were analyzed by IM-MS. 
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DTIM-MS spectra were obtained using a custom IM-time-of-flight MS with a 
MALDI source (MALDI-IM-TOFMS) operating at 500 Hz with a frequency-tripled Nd:YLF 
laser with a wavelength of 349 nm. Analysis was aided by custom visualization software 
(Ionwerks, Inc., Houston, TX). 2,5-dihydroxybenzoic acid (DHB) was used as the MALDI 
matrix in a matrix:analyte ratio of approximately 100:1. The drift tube was pressurized 
with helium to ca. 4 Torr for all experiments. The collision cross section for each labeled 
and unlabeled peptide was calculated using equation 1.1, which is based on the kinetic 
theory of gasses.8 Collision cross sections for several peptides labeled with each of the 
five lanthanides were also calculated. 
 
3.3 Results and discussion 
 
Due to the curvature of the peptide correlation function,9 two possible shift 
reagent strategies (as illustrated in Figure 3.1) may be imagined, each with their own 
strengths and challenges: (i) high cross section labels of relatively low mass, as 
represented by parachutes and (ii) high mass shift reagents of low cross section, 
illustrated as anchors. The high density nature of the lanthanide-based shift reagents 
isolates labeled peptide signals in an area below the peptide correlation function. High 
density labels have enhanced utility on peptides of low mass (i.e. peptide mass below 
ca. 2000) since the slope of the peptide correlation function is more vertical than at 
higher masses. 
Initial high density shift reagent experiments were conducted using several model 
peptides. Cysteine containing peptides, in the presence of several cysteine free 
peptides, were labeled as illustrated in Scheme 3.1. The unlabeled peptides remain near  
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Figure 3.1. A cartoon illustrating the two types of IM-MS shift reagents.  Low density 
(high collision cross section and low mass) shift agents are illustrated as balloons. High 
density shift agents (high mass and low collision cross section) are shown as anchors. 
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Figure 3.2. An illustration of a peptide (NCREKA) labeled with the cysteine specific IM-
MS shift reagent incorporating a lanthanum atom. Several other unlabeled peptides are 
shown for comparison to the unlabeled peptide correlation band.    
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the peptide correlation band (shown as a solid black line in Figure 3.2), while the labeled 
peptide was shifted to an area in conformation space outside of the predicted peptide 
correlation band. Expanding on initial promising results, a much larger set of peptides of 
varying structure and sequence were analyzed. Collision cross sections of both labeled 
and unlabeled peptides were measured. The results of these calculations are shown 
graphically in Figure 3.3 and in tabular format in Table 3.1.  
The high mass of the lanthanide metal provides the shift necessary to isolate 
labeled peptide signals in conformation space (Figure 3.3). While most peptides fall 
within 5-7% of the peptide correlation function10 (illustrated as a solid black line), 
modification by high density shift reagents results in >15% average deviation (Table 3.1). 
This high degree of deviation from the narrow peptide correlation band ensures that 
labeled peptide signals (i.e. peptides that contain a specific functionality) are easily 
identifiable in conformation space. 
The curving nature of the peptide correlation band causes high density shift 
reagents to have a larger relative shift for lower mass peptides. Table 3.1 illustrates this 
effect as the deviation from the peptide correlation band tends to decrease from about 
20% for low mass peptides to about 10 % for peptides approaching 2000 Da. The choice 
of lanthanide metal does not significantly affect the deviation of a labeled peptide. For 
example, all five of the metals used (La, Lu, Tm, Tb, Ho) offer a similar deviation from 
the correlation band, as illustrated in Figure 3.4. 
IM-MS shift reagents can aid in the rapid identification of peptides that contain 
specific functionality in a complex mixture of peptides. An unlabled tryptic digestion of 
Lysozyme was analyzed (i.e. a peptide mass mapping experiment11-12) on IM-MS 
instrumentation resulting in many positively identified peptides (Figure 3.5a). The three 
  
Figure 3.3. An illustration of the collision cross sections of various cysteine-containing 
peptides labeled with the thiol specific IM-MS shift reagents shown in Scheme 1. 
Labeled signals (using both lanthanum and lutetium) are shifted to an area in 
conformation space not predicted to contain peptide signals in the absence of labeling, 
illustrated as the grey area.  
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                                                               Collision Cross Section (Å2)a Relative Deviation (%)   
 
Peptide Sequence
Average m/z 
[M+H]+
Untagged 
[M+H]+
Tagged 
DOTA+La
Tagged 
DOTA+Lu
Tagged 
DOTA+La
Tagged 
DOTA+Lu        
NCREKA 720.80 180.0 ± 0.3 242.4 ± 0.2 241.5 ± 0.4 -20.2 -21.9 
CLRRASLG 876.07 218.1 ± 0.1 279.2 ± 0.3 277.7 ± 0.3 -11.1 -16.2 
KWWCRW 965.17 229.7 ± 0.1 291.2 ± 0.9 279.0 ± 0.2 -14.0 -18.7 
CYFQNCPRG-NH2d 1087.27 233.5 ± 0.1 360.6 ± 0.7 342.6 ± 0.6 -16.4 -21.9 
DYCNVLNKEF 1245.40 268.7 ± 0.2 321.9 ± 0.5 313.7 ± 0.8 -14.1 -17.7 
CQKLDKSFSMIK 1428.77 319.1 ± 0.8 345.0 ± 0.7 340.3 ± 0.6 -13.0 -15.0 
NRVYIHPCHLLYYS 1779.09 332.0 ± 0.8 393.2 ± 0.3 394.0 ± 0.9 -9.5 -10.0 
RAARISLGPRCIKAFTE 1890.27 352.5 ± 0.6 401.8 ± 0.2 400.9 ± 0.7 -9.8 -10.7 
 
 
 
 
 
 
Table 3.1. Tabular data represented in Figure 3.3. The collision cross sections (average of n=5 measurements) of labeled peptides 
show a negative deviation of approximately 10-20% from the peptide correlation band. 
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Figure 3.4. A graphic representation showing the collision cross sections of several 
peptides labeled with lanthanum, terbium, holmium, thulium, and lutetium. The specific 
lanthanide metal used does not have a significant effect on the average shift of the 
signal from the peptide correlation band. 
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Figure 3.5. (A) A plot of IM-MS conformation space for an underivatized cysteine-
reduced tryptic digest of Hen Egg White Lysozyme. In this plot, 12 tryptic peptides were 
positively identified of which 3 contain cysteine as labeled, which are also indicated in 
the mass spectrum by open circles. Note that all of the peptides fall within the 
conformation space predicted for underivatized peptides. (B) A plot of IM-MS 
conformation space for the same tryptic digest of Lysozyme, whereby cysteine residues 
are covalently derivatized with the cysteine specific shift reagent coordinated with La. 
Although the same 12 peptides are identified, the derivatized cysteine containing 
peptides are mobility shifted to regions where peptide ions are not predicted to occur. 
For comparison purposes, the ovals indicate where the peptide signals are observed in 
the absence of labeling (i.e. in A) with arrows illustrating where these signals are 
observed when derivatized, which are also indicated in the mass spectrum by filled 
circles. The peak labeled “*” corresponds to the cysteine reducing agent DTT which has 
incorporated two shift reagent+La tags. Peaks observed at -44 Da relative to the 
derivatized peptides (and the DTT peak) correspond to in-source decay loss of CO2 from 
a carboxylic acid moiety on the shift reagent. The solid lines are to assist invisualizing 
the correlation of collision cross section versus m/z for peptide ions. 
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  Average m/z ([M+H]+) Collision Cross Section 
(Å2)a
 
 
 
 
Peptide Sequence
Amino 
Acid 
Position
 
Underivatized
 
Derivatized
 
Underivatized
 
Derivatized      
 
KVFGR 1-5 606.7501 - 168.93 ± 0.27 - 
HGLDNYR 15-21 874.9370 - 207.61 ± 0.30 - 
WWCNDGR 62-68 937.0305 1600.2645 212.28 ± 0.12 265.28 ± 
0.72 
GTDVQAWIR 117-125 1046.1780 - 237.39 ± 0.80 - 
GYSLGNWVCAAK 22-33 1269.4737 1932.7077 277.08 ± 2.43 342.87 ± 
3.65 
CKGTDVQAWIR 115-125 1277.4968 1940.7308 271.03 ± 1.45 -a
FESNFNTQATNR 34-45 1429.4977 - 278.12 ± 0.35 - 
IVSDGNGMNAWVAWR 98-112 1676.9059 - 318.41 ± 0.48 - 
NTDGSTDYGILQINSR 46-61 1754.8621 - 317.98 ± 0.79 - 
 
 
 
 
 
 
 
Table 3.2. A comparison of the m/z and collision cross sections determined for cysteine containing peptides that are underivatized 
and derivatized with a cysteine specific shift reagent incorporating lanthanum . All peptides were generated from a tryptic digestion of 
hen egg white Lysozyme. The boldfaced peptides each contain a cysteine residue. aCKGTDVQAWIR was positively identified by 
mass and by use of the shift reagents, however the labeled peptide abundance was too weak (since it has a missed cleavage) to 
obtain an accurate collision cross section measurement. 
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identified cysteine containing peptides are marked for clarification. Note that all peptides 
fall within the peptide correlation area, whose midline is illustrated as a solid black line. A 
separate Lysozyme digest was labeled and analyzed, yielding many peptides within the 
predicted correlation band in addition to three labeled cysteine containing peptides that 
were shifted to a location where peptide signals are not predicted to occur (Figure 3.5b). 
This significant shift in conformation space permits a rapid and simple identification of 
cysteine containing peptides from a complex mixture of peptides. Table 3.2 summarizes 
the identification of cysteine containing peptides from a Lysozyme digestion. Collision 
cross sections are shown for comparison purposes. 
In addition to identification of specific functionality in peptides and proteins, 
lanthanide-based labels may also be used for relative quantitation purposes, as 
previously described13-15 in Chapter 2. Analysis of relative quantitation experiments may 
be completed on IM-MS instrumentation in addition to one dimensional MALDI TOFMS. 
Figure 3.6 illustrates the similarity of data between the two instrument platforms. 
Panel A shows the type of data acquired using MALDI TOFMS (Chapter 2). Panel B 
represents both the extracted mass spectrum (upper portion) and a view of IM-MS 
conformation space (lower portion) acquired using a custom IM-MS instrument 
described previously in this chapter.  
 
3.4 Conclusions 
 
This chapter has focused on the development and use of IM-MS shift reagents 
for the rapid identification of specific chemical functionality in a complex mixture of 
peptides. The shift reagents described here consist of a cysteine or primary amine  
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Figure 3.6. A comparison of the types of data collected using MALDI TOFMS (panel A) 
and drift tube IM-MS instrumentation. The spectra illustrate a relative quantitation 
experiment whereby a peptide (DYCNVLNKEF) was labeled using the cysteine specific 
label and La/Lu metal system in a 1:5 ratio. Panel B illustrates the extracted mass 
spectrum as well as the 2D conformation space. 
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specific label that is also capable of incorporating a lanthanide metal atom. The 
lanthanide metal provides the necessary properties of high mass and relatively low 
collision cross section required to shift peptides signals to an area in conformation space 
outside of the predicted area for unlabeled peptides. The relatively large mobility shift 
afforded by these lanthanide-based labels facilitates rapid identification of cysteine 
containing peptides. 
Since the label can incorporate any lanthanide metal, relative quantitation 
experiments are possible by tagging various experimental states, each with a different 
lanthanide. Relative quantitation information may also be obtained using IM-MS 
instrumentation. An advantage of this type of analysis is instant identification of labeled 
peptides and rapid quantitation analysis. The use of multiple labels and lanthanides 
offers the possibility of multiplexed experiments whereby multiple functionalities are 
identified simultaneously. 
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CHAPTER IV 
 
MULTIPLEXED ANALYSIS OF PEPTIDE FUNCTIONALITY USING METAL 
CHELATION LABELS 
 
4.1 Introduction 
 
IM-MS shift reagents take advantage of the narrow peptide correlation bands in 
conformation space by shifting specific signals to an area in which peptides signals are 
not ordinarily predicted to occur in the absence of labeling. The curvature of the peptide 
correlation band ensures that the mass (and small cross section increase) added offer a 
significant shift for rapid identification of labeled peptides. 
Analysis of multiple protein samples simultaneously has been completed 
previously. Most of these experiments have centered around the use of gels in a 
differential gel electrophoresis (DIGE) experiment.1 Classically 2D gels are used for this 
purpose. The first dimension of separates proteins based on their isoelectric point. 
Separation in this manner separates proteins that vary in native solution-phase charge. 
The second dimension of separation is a typical gel electrophoresis experiment whereby 
smaller molecules travel faster (and thus further through the gel) than larger molecules. 
Although not perfect, higher mass proteins tend to adopt larger structures, restricting 
their movement through the gel compared to small molecules. 
Multiplex labeling is accomplished through the use of cyanine dyes. Briefly, 
several dyes (each with a different excitation wavelength) are used to modify protein 
samples, one dye for each protein sample. For example, a control will be labeled with 
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one dye while an experimental sample is labeled with another dye. The samples are 
mixed and analyzed by 2D gel electrophoresis. The gel is analyzed using different 
wavelengths of excitation light to visualize the control and experimentally labeled 
samples independently. Using cyanine dyes allows for a general indication of changes in 
the protein expression level and corrects and is not limited by gel drift since the two 
samples are analyzed on the same gel. 
The multiplex labeling described in this chapter is envisioned as similar to the 
classical multiplex dye labeling utilized for 2D gel analysis; however peptides are labeled 
at multiple orthogonal functionalities using two different lanthanide metals. The use of 
two labels with two different metals provides for several interesting experiments. For 
example, MS/MS analysis would allow for site identification of the two functionalities 
labeled.  Additionally, ICP-based analysis could provide a relative ratio of the 
functionalities labeled. 
 
4.2 Experimental 
 
All peptides were purchased from American Peptide Company (Sunnyvale, CA) 
and proteins, as well as matrices, were purchased from Sigma Aldrich (St. Louis, MO). 
Lanthanide metals (as LnCl3 hydrates) were purchased from Strem Chemical for 
Research (Newburyport, MA) and Sigma Aldrich. Functionally specific lanthanide-
chelating labels were purchased from Macrocyclics (Dallas, TX). All common solvents 
were also purchased from Sigma Aldrich. Deionized water was obtained from a Millipore 
(Bedford, MA) water purification system. All chemicals purchased were used without 
further purification.  
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Peptides with differing numbers of primary amine sites (e.g. N-terminal primary 
amine and Lys residue side chains) were selectively labeled by an IM-MS shift reagent 
consisting of a lanthanide-chelation moiety, a short linker region, and an N-
hydroxysuccinimide moiety for the specific modification of primary amine sites. Labeling 
reactions proceeded as illustrated in Scheme 4.1 whereby primary amine sites were 
modified by adding a ten-fold molar excess of amine specific label at a borate buffered 
pH of 10. Subsequent to amine modification, a lanthanide (Ln(III)) metal atom is chelated 
within the macrocycle by adding a ten-fold molar excess of Ln(III) and heating to 80˚C at 
an acetate buffered pH of 5.7.2 
All labeled peptides were desalted using ziptips (Millipore) prior to analysis. MS 
analysis was completed on an Applied Biosystems (Carlsbad, CA) Voyager DE MALDI 
TOFMS using 2,5-dihydroxybenzoic acid (DHB) as the matrix. Ion mobility analysis was 
completed on a Waters Synapt G2 ion mobility-mass spectrometry instrument. Labeled 
peptide samples were spotted onto a MALDI target plate using the dried droplet method 
with 2,5-dihydroxybenzoic acid (DHB) as the matrix in a matrix:analyte ratio of 
approximately 100:1. 
Model cysteine-containing peptides were labeled using a shift reagent consisting 
of a lanthanide-chelation moiety, a short linker region, and a maleimide group for the 
selective modification of the thiol side chain of cysteine residues. Labeling reactions 
proceeded as shown in Scheme 4.1. Briefly, a Ln(III) metal was chelated with the 
macrocycle by heating a ten-fold excess of metal and label to 80˚C at an acetate 
buffered pH of 5.7. Subsequent to metal chelation, cysteine-containing peptides were 
modified by adding a ten-fold excess of lanthanide-shift reagent complex to peptides at 
an acetate buffered pH of 5.7.2 All labeled peptides were desalted using ziptips 
(Millipore) prior to MS analysis as detailed above. 
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Scheme 4.1. An illustration of the labeling reactions for primary amine specific (R1= N-
hydroxysuccinimide) and cysteine specific (R2=maleimide) shift reagents. The 
incorporation of the lanthanide metal (Ln III) provides the necessary properties of high 
mass and the relatively small increase in collision cross section required for high density 
shift reagents. 
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Proteins used for simulation of complex mixtures were proteolyzed according to 
previously published methods.3 Briefly, proteins were reduced (if required) and heat 
denatured at 90˚C. Ammonium bicarbonate buffer (pH ~8) was added followed by trypsin 
in a ratio of 1:40 w:w. Digestion was allowed to proceed overnight (approximately 18-24 
hours) at 37˚C. Upon completion, the resulting peptides were desalted using C18 spin 
columns (Pierce, Rockford, IL). The resulting peptides were then labeled with cysteine 
specific or primary amine specific shift reagents as shown in Scheme 4.1. Labeled 
peptides were desalted once again using ziptips prior to analysis. 
Post-ionization IM-MS separations selective for phosphorylation residues were 
demonstrated using bovine beta-casein in a proof-of-concept experiment. The protein 
was dissolved in ammonium bicarbonate buffer (pH ~8) and thermally denatured at 90˚C 
for 20 minutes and quenched at -20˚C.3 Reduction and alkylation was not performed as 
there are no dicysteinyl bonds in this protein. The protein was subsequently digested 
with trypsin in a 1:40 w:w ratio for 16-20 hours at room temperature and desalted using 
C18 spin columns prior to derivatization. 
Phosphopeptide specific labeling reaction proceeded as illustrated in Scheme 4.2 
whereby tryptic peptides were subjected to a one-pot beta elimination (Scheme 4.2i)/ 
Michael addition4 (Scheme 4.2ii) reaction whereby the site of phosphorylation loses 
phosphoric acid, followed by the addition of an ethanedithiol linker. The beta elimination/ 
Michael addition reaction mixture consisted of 2.5 mM EDTA, 0.2M ethanedithiol, 0.5M 
NaOH, 1.5M acetonitrile, 1.5M ethanol, 5M DMSO, and water. The reaction was allowed 
to progress for 1-2 hours under a nitrogen atmosphere at 55˚C in a manner similar to 
reaction conditions described previously.5-7 The samples were then neutralized and 
purified by gel filtration (Sephadex G-10, Sigma) and reaction completion was confirmed 
by MALDI TOFMS. Subsequently, the thiolated peptides were labeled with a ten-fold  
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Scheme 4.2. A schematic diagram of the labeling reactions utilized for selective labeling 
at sites of phosphorylation.  
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excess of maleimido-DOTA (Scheme 4.2iii) in a mixture containing acetate buffer (pH 
5.7) and DMSO in a 1:1 ratio (v/v), resulting in a covalent modification of the free 
sulfhydryl group. Finally, a lanthanide metal was chelated to the macrocycle portion of 
the tag by adding a 100-fold molar excess of metal to peptide and heating to 80˚C for 45 
minutes (Scheme 4.2iv).2 
 Differentially labeled samples were then combined and desalted, using C18 spin 
columns, and analyzed by MALDI IM-MS. Peaks exhibiting a negative deviation from the 
peptide correlation function were selected for fragmentation in the transfer portion of the 
Synapt G2 instrument. 
 Multiplexed labeling was accomplished by labeling primary amines first (including 
lanthanide incorporation). In a separate reaction, a different lanthanide metal was 
chelated with the cysteine specific label. The lanthanide-cysteine label complex was 
then used to modify cysteine residues on the labeled peptide. Different metals can be 
used to optimize the total mass shift of the multiply labeled peptide or enhance ICP 
analysis. Samples subjected to multiplex labeling were desalted using ziptips prior to MS 
and IM-MS analysis as described above. 
 The fragmentation efficiency of both unlabeled and labeled peptides was also 
investigated. Peptides (either unlabeled or Tb labeled) were fragmented under collision 
induced dissociation conditions (CID) using a Waters Synapt G2 instrument. The 
collision energy was titrated from very low, which did not fragment the peptides to a 
significant amount, to high energy until complete fragmentation of the parent ion was 
observed. The fragmentation efficiency (a ratio of all signal excluding the parent ion to all 
signal, including the parent ion) was plotted as a function of collision energy for analysis.  
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4.3 Results and discussion 
 
 High density shift reagents function by shifting specific peptide signals to an area 
in IM-MS conformation space where the parent signal is not predicted to occur in the 
absence of labeling. The high mass of the lanthanide and the minimal branching of the 
label ensures that labeled peptide signals are shifted to an area below the peptide 
correlation band. Qualitatively, shift reagents allow for rapid, confident identification of 
peptides since it is known that all shifted signals contain a specific functionality.  
Labeling primary amines ensures that peptides from a complex mixture (e.g. a tryptic 
digest) each receive at least one label. Peptides that contain a lysine residue are labeled 
twice (i.e. the N-terminus and Lys side chain). While the correlation band is shifted since 
each peptide is labeled, the addition of subsequent labels shift the signal even further 
from the unlabeled peptide correlation band. In addition, lanthanide-based shift reagents 
are useful in the site localization of specific functionality since the labels remain intact 
during typical tandem MS fragmentation conditions. 
 Protein phosphorylation constitutes a large portion of biologically important post-
translational modifications, and elucidating the site of phosphorylation presently remains 
challenging. Challenges in phosphoproteomics continue to lie in the modification’s lability 
and the substoichiometric amounts available. By selective labeling of this PTM with a 
high density shift reagent followed by IM-MS analysis, phosphorylated peptides and 
proteins are shifted to regions of IM-MS conformation space where signal is not 
predicted to occur. In this manner, phosphorylated peptides may be identified for 
fragmentation and further analysis (i.e. site identification) in a manner more rapid and 
efficient than traditional data-dependent tandem MS methodologies. 
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 Bovine beta-casein, a model phosphorylated protein, was selectively labeled with 
a holmium chelated mobility shift label to visually identify phosphorylated peptides in 2D 
IM-MS conformation space prior to fragmentation. The resulting underivatized tryptic 
peaks that establish the peptide correlation function and the derivatized phosphorylated 
peptides are shown in figure 4.1a. Upon visualization of a negative deviation from the 
peptide correlation function, mobility shifted phosphorylated peptides were selected for 
fragmentation to elucidate the site of phosphorylation. One mobility-shifted peak was 
identified as a holmium-labeled tryptic peptide FQpSEEQQQTEDELQDK (where p 
indicates phosphorylation of the following amino acid, in this case serine), was identified.  
The tandem spectrum is shown in figure 4.1b. The expected b/y series ions were 
observed, including b ion coverage from the b3 to the b15 ion (b14 was observed but was 
not considered significant as it did not have a sufficient S/N value), labeled y14 and y15 
ions, and several labeled water loss ions with little evidence for fragmentation of the 
label. The stability of this label enables predictable mass shifts of anticipated b and y 
ions8-10 which gives an indication of the site of modification previously phosphorylated. 
Furthermore, because this tag is not labile and does not show phosphorylation site 
rearrangement, it has an added advantage of more confident phosphorylation site 
assignment.11 
 Multiplexed labeling (i.e. labeling multiple functionalities on a single peptide) is 
possible using lanthanide-based shift reagents. Using a different lanthanide metal for 
each label affords the ability to quantify the relative ratio of multiple functionalities on a 
single peptide using an ICP based instrument. The relative ratio of functionalities would 
allow for higher confidence in assigning peptide identification. Since the labels remain 
intact through collision induced dissociation, tandem MS experiments (Figure 4.2) for 
peptide identification and functionality site localization are possible. 
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Figure 4.1. (a) 2D IM-MS plot of derivatized tryptic beta-casein. The signal 
corresponding to derivatized FQpSEEQQQTEDELQDK (indicated in a white dashed 
circile) exhibits a negative deviation from the peptide correlation line (indicated by a 
black dashed line), facilitating visual identification prior to fragmentation. (b) 
Fragmentation spectrum of a Ho-labeled tryptic beta-casein phosphorylated peptide 
having the sequence FQpSEEQQQTEDELQDK. Spectral peaks from 1000 m/z to 2730 
m/z were enhanced 10x to increase visibility of b and y spectral assignments, as the 
[M+H]+ ion dominated the spectrum. Observed fragmentation peaks are indicated on the 
peptide sequence above the spectrum as well as in the spectrum. Fragmentation 
coverage of 80.0% and 13.3% of the labeled peptide was observed for b and y ions, 
respectively. Importantly, all of the anticipated ions corresponding to labeled positions 
are observed, demonstrating the utility of this label for phosphopeptide site identification 
as well as relative quantitation. 
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Figure 4.2. (A) A representation of IM-MS analysis of multiplexed labeling. Briefly, a 
peptide (sequence shown in part (B)) was labeled at both the N-terminal primary amine 
(Tb labeled) and a cysteine residue (Ho labeled) according to Scheme 4.1. Panel (A) 
illustrates the peptide correlation band (illustrated as a dashed line) showing a tryptic 
digest of bovine serum albumin. The lower peaks are due to the multiply labeled peptide 
shown in (B). The labeled peptide was subjected to MS/MS to ensure confident 
identification and label stability. 
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Labeled and unlabeled peptides were fragmented using MALDI TOFMS (Waters 
Synapt G2). Each peptide was fragmented at various energies under CID conditions. 
The fragmentation energy (Σ Fragment signal / Σ Total signal) of the unlabeled peptide 
was plotted versus collision energy in arbitrary units, as described previously.12  
Fragmentation data for labeled peptides were also collected; however the collision 
energy was corrected using a linear degrees of freedom (DOF) correction (Equation 4.1) 
in order to offset the increase in collision energy required due to higher mass.13  
                                    Eq. 4.1 
Fragmentation data was plotted for both labeled and unlabeled peptides. The 
curves (Figure 4.3, 4.4, and 4.5) illustrate that a differing amount of energy (relative to 
the corresponding unlabeled peptide) is required for fragmentation of 50% of the parent 
signal. For example, some labeled peptides require more energy than the unlabeled 
peptide (Figure 4.3 for example) while some labeled peptides require less energy 
(Figure 4.4 for example). This shift in required collision energy is attributed to sequence 
effects since more acidic peptides tend to fragment more easily. The removal of a basic 
site by the addition of the label is thought to increase the acidic nature of the peptide 
sequence. If there are several other basic sites that remain unlabeled, the effect seems 
to be small, however if one of the last basic sites is removed by the addition of the label, 
the acidic nature of  the peptide increases more.  
The mobile proton model13-15 specifies that a peptide may be protonated at 
specific locations (e.g. basic residues) more frequently than other locations within the 
peptide. In order for fragmentation to occur, however, this ionizing proton must shift to 
other portions of the peptide for rearrangement reactions leading to peptide fragments. 
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Peptides that contain arginine tend to require more fragmentation energy.16 The 
fragmentation data presented here confirms this idea.  
Upon labeling, peptides that contain arginine (which is not labeled) retain a highly 
basic site while losing a less basic site (i.e. Lys residue side chain or the N-terminus) to 
the label. These labeled amines become amides. Alternatively, peptides that do not 
contain arginine are labeled at their most basic site, making the entire peptide more 
acidic. Acidic (or neutral) peptides do not localize the ionizing proton as well since it 
binds to the amide nitrogen or oxygen atoms. Since many of the possible locations for 
the proton fall within a narrow range of proton affinity (compared to Lys or Arg), acidic 
peptide fragment more easily. 
 
 
4.4 Conclusion 
 
 IM-MS shift reagents can be used to gain several types of information from 
samples. These reagents can be used to identify several relevant chemical 
functionalities, including primary amine sites, cysteine sites, and phosphorylation sites. 
In addition, the use of different metals for different samples affords the utility of relative 
quantitation experiments. Primary amine sites work well as targets for relative 
quantitation labels since nearly all tryptic peptides have at least one (or more) primary 
amine sites. Cysteine labeling can be used to locate cysteine residues within peptides, 
thus increasing the confidence of peptide identification. Furthermore, phosphorylation 
sites may be elucidated in a manner more rapid and with great confidence than 
traditional data-dependent tandem MS methods. 
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Figure 4.3. A fragmentation efficiency curve for a peptide with the sequence Ac-
RYYRIK-NH2. In this particular case, the labeled peptide required more energy for 
fragmentation of 50% of the parent signal. 
 
 
Figure 4.4. A fragmentation efficiency curve for a peptide with the sequence Ac-
YGGFMTSEKSQTPLVTL. Unlike figure 4.3, the labeled peptide in this case required 
less energy for fragmentation of 50% of the parent signal. 
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Figure 4.5. A fragmentation efficiency curve for a peptide with the sequence 
SLRRSSCFGGR. This labeled peptide required nearly the same energy for 
fragmentation of 50% of the parent signal compared with the unlabeled curve for the 
same sequence.  
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Multiplexed labeling can also be used to rapidly identify specific peptides that contain 
both primary amine sites (e.g. Lys residues) and cysteine residues. Further, these 
multiply labeled functionalities can be quantified using ICP based instruments. For 
example, one lanthanide can be chelated to the primary amine label and a different 
lanthanide could be chelated to the cysteine specific label. ICP experiments can 
elucidate the relative ratio of these two functionalities. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
5.1 Summary and conclusions 
 
 In this dissertation, high density IM-MS shift reagents were described and 
their utility explored through a variety of samples and experimental conditions. Firstly, 
the use of IM-MS provides a rapid means of distinguishing biomolecular classes in a 
complex mixture of biomolecules. The shift reagents described here offer further 
information in that signals containing specific peptide functionalities (e.g. primary amine 
sites, cys residues, phosphorylation) may be shifted out of the peptide correlation band 
where they are predicted to occur to an area of conformation space not ordinarily 
predicted to contain peptide signals in the absence of labeling.  
 Initial development of lanthanide base IM-MS shift reagents proceeded using 
model peptides. Peptides were chosen in order to provide a range of masses as well as 
location of the target moiety within the peptide sequence, the number of targeted 
moieties in the peptide, and the overall sequence of the peptide. Early studies focused 
on the relative quantitation (Chapter II) and outlining the shift of labeled peptides from 
the unlabeled peptide correlation band in IM-MS conformation space (Chapter III). 
 Furthermore, the ability to label multiple types of functionalities on a single 
peptide with different lanthanide metals was also explored (Chapter IV). For example, 
peptides containing both primary amine and cysteine sites were chosen. Primary amine 
sites were labeled with one lanthanide metal while cysteine sites were labeled with 
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another metal. The multiply labeled peptides were analyzed by MS and tandem MS. The 
different labels were determined to be suitable for site identification of multiple 
functionalities on a single peptide. Additionally, labeling multiple functionalities (each 
with a different lanthanide metal) would allow for experiments to determine the relative 
ratio of labeled functionalities upon analysis using inductively coupled plasma 
instrumentation. 
 More complex samples were required in order to shift from proof of concept 
experiments toward biologically relevant samples. Toward this goal, the next 
development was labeling complex mixtures of peptides. More complex samples were 
simulated using tryptic proteolysis of model proteins. Digestion in this manner gave 
samples with peptides of varying length, sequence, number of targeted moieties, and 
ionization efficiency. Another step toward more complex samples was through 
proteolysis of multiple proteins in a single reaction. Using multiple proteins gave many 
more peptides, each different in sequence, length, and number of targeted moieties.    
 The ability to use different lanthanide metals to provide the density required 
for an IM-MS shift allows for relative quantitation using these same shift reagents. The 
different lanthanides used function similar to different isotopes used by other stable 
isotope methods (i.e. ICAT or SILAC). One advantage of using lanthanides, however, is 
the larger mass shift between differentially labeled samples and the flexibility to tune the 
mass shift to the specific sample. The larger mass shift and flexibility of the metal system 
avoids overlapping of the isotope cluster of high mass peptides, a potential limiting factor 
of ICAT and SILAC. Additionally, the lanthanide based label remains intact through 
collision induced dissociation (CID) processes, enabling confident sequence 
identification since the labels provides a frame of reference (i.e. doubly primary amine 
labeled tryptic peptides contain a Lys reside at the c-terminus).  
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 Table 5.1. A comparison of the different properties of each metabolic or chemical 
method of stable isotope incorportation. 
 The lanthanide labels described here offer several advantages over other 
stable isotope quantitation methods in cost, targeted functionality, and ease of use 
(Table 5.1). Lanthanide based labels provide relative quantitation capability by modifying 
either primary amines or cysteine residues. The ability to label primary amines allows for 
the relative quantitation of proteins that do not contain cysteine (such as the histones) 
where ICAT would not work. Additionally, it provides good accuracy at a much lower cost 
than the AQUA method. Lower cost allows for the relative quantitation of proteins and 
peptides on a proteome wide scale without great expense. Another final advantage is 
that while the label remains intact through MS/MS conditions (allowing for site 
identification), tandem MS is not required as it is using iTRAQ. 
 Overall, this dissertation describes the development of IM-MS shift reagents, 
which may be used to extract more information from biochemical analyses than allowed 
by one dimensional MS experiments. The separation of biological classes by IM-MS 
allows for easy identification of signals arising from peptides, however specific sequence 
information still requires time consuming analysis by tandem MS. The use functionally 
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specific IM-MS shift reagents allows for the rapid visualization of specific chemical 
functionalities present in a complex sample. 
 
5.2 Future directions 
  
 Through the experiments described here, progress was made on the 
development, characterization, and analysis properties of high density IM-MS shift 
reagents. There exists, however, many opportunities for further development and 
application of this class of reagents. Several future directions are described here. 
 Further development of the use of the primary amine and cysteine shift 
reagents described in this dissertation could proceed through analysis of more complex 
and biologically relevant samples. For example, development of analysis procedures for  
whole cell lysate would open a new area of research. The ability to use different metals 
for relative quantitation purposes would be useful for the analysis of different cell states 
under control and experimental conditions. The multitude of lanthanides available (and 
the ability to choose a metal system that best suits the analysis) would allow for relative 
quantitation of multiple samples in a single mass spectrum.  
 Furthermore, analysis of clinically relevant samples is possible, since sample 
viability is not a requirement as it is with SILAC. Blood or other fluid analyses could be 
analyzed for relative quantitation of the protein component in response to drugs or other 
external stimuli. It may be possible to use these shift reagents for analysis of clinical 
samples before and after disease treatment, for example. 
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 In addition to fluid samples, analysis of tissue samples (progress described in 
Appendix B) could also be developed further. Currently mouse brain tissue has been 
studied for development of in situ labeling reactions. Further development of this type of 
reaction could proceed through mouse or other animal tissue toward the goal of analysis 
of human tissue suspected to be affected by diseases such as cancer. Use of the shift 
reagents to aid in the analysis and identification of the proteins present in these types of 
samples would be beneficial. Furthermore, the use of the label allows for site 
identification of the tagged functionality, allowing more confidence in the sequence 
identification. 
 Another route of development is through synthesis of new classes of shift 
reagents. Progress toward the synthesis of a new shift reagent that incorporates a MS 
ionization enhancing moiety in the linker region of the label is described in Appendix A. 
The incorporation of ionization enhancing moieties (e.g. an arginine residue, as in 
Appendix A) would allow for analysis of less abundant peptides and proteins. The 
addition of a charge enhancing moiety would also allow for easier analysis of more 
acidic peptides.  Furthermore, ionization efficiency studies would be required to 
determine the extent of the effect – i.e. are all peptides enhanced equally or does the 
addition of an arginine residue help to even out the ionization of peptides across a wide 
variety of pI values. 
 Synthesis of a different ionization enhancing label consisting of a linker region 
(a CR dipeptide), a thiol terminus, and a macrocycle is in progress through a 
collaboration with the Harth research lab. This label is being synthesized concurrently 
with the label described in Appendix A in order to arrive at a functioning shift reagent 
label. Currently, the dipeptide has been synthesized and tentatively confirmed by NMR 
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analysis. Further NMR analysis would be required for a positive identification. The 
addition of the macrocycle is ongoing.   
 The specific structure described here (containing a thiol terminus) is intended 
for use in labeling phosphopeptides. Many phosphopeptides show low ionization and are 
phosphorylated in substoichiometric amounts, creating challenges in their analysis. The 
additional requirement for small sample size and analysis of proteins of low abundance 
presents further challenges in their analysis. Great progress was made in the synthesis 
of this label; however the last deprotection and addition of the macrocycle still presented 
challenges.    
 Further development in the use of shift reagents could also come from 
development of shift reagents of a modular design, as shown in Figure 5.1. This modular 
design would allow for easy insertion or deletion of functionality from the linker region of 
the label during synthesis. For example, a betaine charge enhancing moiety may be 
substituted for the arginine residue. Alternatively, a biotin moiety may be substituted, 
allowing for rapid enrichment of labeled species from a complex mixture.  
 The terminal reactive moiety is also envisioned to be easily changed within 
the modular design. For example, the thiol moiety could be exchanged for a primary 
amine specific moiety in order to provide enhanced signal for labeled primary amines. 
Alternatively, other post translational modifications or amino acid residues could be 
targeted using the appropriate terminal functionality.  
 Development of shift reagents for ubiquitination, for example could be an area 
of beneficial research. Further modifications of the shift reagent structure could provide 
other benefits such as reduction of steric hindrance leading to shorter reaction times. In 
short, the future development of high density IM-MS shift reagents could proceed along  
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Figure 5.1 A representation of the intended modular design of future IM-MS shift 
reagents. A class of shift reagents is envisioned whereby synthesis proceeds in a 
modular fashion. For example, different charge enhancing moieties (e.g. arginine 
residue or betaine) may be used. Alternatively, a biotin moiety may be substituted, 
allowing for enrichment of the labeled species. Such a modular design allows for great 
flexibility in the mixing or exchange of different functionality within the linker region or the 
terminal functionality. 
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several routes toward becoming a more useful and developed method for analysis of 
biological samples. 
 Development of a class of easily synthesized shift reagents as described here 
would allow great flexibility in the analysis of many different chemical functionalities. The 
addition of one (or multiple) charge enhancing moieties within the linker region would 
ensure that even acidic species (which have low ionization efficiency) can be analyzed. 
The ability to exchange terminal reactive moieties allows for rapid flexibility and 
application toward different labeling targets as the field of mass spectrometry based 
proteomics progresses.  
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APPENDIX A 
 
THIOL TERMINATED SHIFT REAGENT SYNTHESIS PROGRESS 
 
 The shift in proteomics toward analysis of smaller samples and less abundant 
proteins has pushed the limits of current instrument sensitivity. While MS offers much 
better sensitivity than other methods like NMR or 2D gels, further gains in sensitivity are 
sought. These sensitivity gains could come from several sources, namely optimization of 
instrument hardware and settings, or better ionization efficiency at the source. 
 Methods of enhancing ESI ionization were developed nearly concurrently with 
the development of the source itself. Using an ESI source, higher charge states allow for 
mass measurement using quadrupole instruments, more efficient fragmentation of 
protein analytes, and more signal in tandem MS spectra due to the higher likelihood that 
each fragment will retain some charge. Fragments of low charge state ions (especially 
singly protonated ions common to MALDI) are often neutral since only one fragment half 
retains the parent charge.    
 Supercharging agents, first developed about a decade ago, serve to increase 
the ionization state of large proteins during analysis by ESI. These reagents, commonly 
small molecules mixed in with the analysis solution, can significantly increase the charge 
state of a protein, thereby lowering its m/z value in the spectrum. The increased charge 
has been thought to be due to the additive reducing the surface tension of the water 
droplets in the spray. According to the charge residue model (CRM), lower surface 
tension within the droplets produces ions of higher charge state. 
86 
 The charge residue model is one of two prevailing theories concerning the 
generation of ions using electrospray. Briefly, it states that charged droplets (containing 
ions) emitted from the source experience several cycles of evaporation of solvent 
followed by fission of the droplet, effectively reducing the concentration of ions in each 
droplet below the Rayleigh limit, whereby evaporation of solvent continues. The process 
repeats with the new daughter droplets until all of the solvent has been evaporated, 
leaving only ions in the gas phase. Lower surface tension, provided by the 
supercharging reagents, allows the charged droplet to evaporate to a smaller size before 
reaching the Rayleigh limit.      
 The second model of electrospray ionization, the ion evaporation model, is 
slightly different than the charge residue model. The ion evaporation model states that 
after emission of charged droplets from the source, ions are pulled individually out of the 
droplet, similar to evaporation. The remaining solvent is eventually evaporated due to 
low pressure and heating in the desolvation region of the source. While these two 
models answer some of the questions remaining about ionization, neither is perfect. It is 
thought that both processes play a role in the production of ions.   
 These supercharging reagents are traditionally used for ESI samples; 
however other methods of enhancing ionization exist for use with MALDI. Ionization in 
MALDI relies on the gas phase basicity of the analyte for coordination of a proton. 
Peptides containing arginine residues (high gas phase basicity, or alternatively, proton 
affinity) ionize much more readily than peptides that contain many acidic residues. 
Furthermore, permanently charged labels consisting of a quaternary amine (betaine 
moiety) or a sulfonium moiety greatly enhance ionization efficiency.  
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 Application of these charge enhancing methods to proteomics analyses using 
MS or IM-MS was envisioned through the addition of ionization enhancing moieties 
(such as an arginine residue) within the structure of the shift reagent label. Toward this 
goal, a thiol terminated shift reagent (Figure A1) was envisioned consisting of a 
macrocycle for lanthanide metal chelation, a short spacer region containing an arginine 
residue (for enhancing ionization), and a thiol terminus for the modification of beta 
eliminated phosphopeptides through Michael addition. Phosphopeptides do not ionize 
well in positive ion mode due to common sequence motifs and the phosphate group.1-2 
Beta elimination of the phosphate group enhances ionization somewhat, however further 
enhancement was desired in order to improve the ease of analysis and make it possible 
to study lower abundance phosphoproteins. 
 Toward this end, a label was envisioned whereby it would function as a shift 
reagent, but also increase ionization. An arginine residue was chosen as the charge 
carrier in the linker region since it has high gas phase basicity and is a common amino 
acid, having two reactive termini – the N-terminus and C-terminus. Starting with arginine, 
a thiol group would be added, followed by a macrocycle to give the complete label 
shown in Figure A1. 
 The synthesis was envisioned as proceeding through a series of amide bond 
forming reactions (Scheme A1). The first reaction uses a diamino compound to modify 
the c-terminus of arginine to a protected primary amine, thus creating an arginine 
residue with two orthogonally protected primary amine groups. The reaction chosen for 
this step was an EDC coupling reaction.3-5 The first primary amine protecting group was 
cleaved and a N-hydroxysuccinimide group was used to modify it. The next group would 
be deprtected and an isothiocyanate group would be used to add the macrocycle. 
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Figure  A1.  A  representation  of  the  proposed  IM‐MS  shift  reagent  intended  to  enhance 
ionization.  An  arginine  residue  is  incorporated  into  the  liner  region  for  this  purpose.  The 
macrocycle  incorporates  the  lanthanide metal, while  the  thiol group  is  reactive  towards beta 
eliminated  phosphopeptides.  The  acetyl  protecting  group  on  the  thiol may  be  cleaved  using 
hydroxylamine. 
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Scheme A1. A representation of the proposed synthesis of the ionization enhancing 
 
 
 
 
 
phosphopeptide shift reagents (5). The first reaction involves modification of the c-
terminus of arginine to give an orthogonally protected di-primary amine version of 
arginine (1). The Fmoc protecting group is cleaved (2) and a protected thiol is added via 
SATP, resulting in compound (3). The CBZ protecting group is cleaved (4), and the 
macrocycle is added via isothiocyanate functionality, resulting in compound (5). 
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  The synthesis progressed starting from fluoronylmethyloxycarbonyl protected 
N-Z-ethylenediamine, 168μL undiluted 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(EDC), 180 mL DI water, and 120 mL absolute ethanol. This mixture was then adjusted 
to pH 4.2 using concentrated HCl. The reaction was allowed to proceed at room 
reaction progress using MALDI TOFMS. The yield (represented as 573/ 396+573) at this 
point was usually 30-40%. The mixture is dried using a rotary evaporator (rotovap) and 
lyophillized yield should be approximately 1.8g. 
used to enrich the desired product (1). A 
contaiminant does not interfere with the next reactions. Briefly, a column of 1.5 inch 
diameter is packed with flash grade silica gel (40-63μm particle size, 60Å pore size) to a 
column height of approximately six inches.6 The solvent system used is 15% methanol in 
mobile phase and run through the column. Using this solvent system, the desired 
product should elute at approximately three column volumes of collected fractionated 
interest for further reactions. The structure of the desired intermediate was tentatively 
confirmed by MS/MS analysis7 as shown in Figure A2, however further analysis by NMR 
arginine (FMOC-Arg-OH). A typical synthesis used 75mg of this starting material, 1.31g 
temperature for 3.5-4 hours. Ziptips (Millipore) were used to desalt an aliquot to check 
frozen overnight. The yield increases dramatically after drydown and freezing. The 
 Flash chromatography purification6 is 
contaminant form of the carbodiimide also coelutes to some extent, however this 
dichloromethane (DCM). The intermediate product is dissolved in a small portion of the 
mobile phase. Upon fractionation, MALDI TOFMS is used to locate the fractions of 
would be required for confident structure assignment. 
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Figure A2. (A) A representation of the structure of the first intermediate in the shift 
reagent synthesis. The theoretical mass of [M+H]+ is 573.3. (B) A tandem MS spectrum 
of the first intermediate shown in (A). The masses listed below the spectrum are 
334.2 238.1 221.1 195.1 193.1 179.1 178.1 165.1 150.1 91.1 
86.1 
identified fragmentation peaks in the spectrum. Many of the high intensity peaks are 
accounted for, however confident structure confirmation requires NMR.  
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 After isolation of the intermediate, the fluoronylmethyloxycarbonyl (FMOC) 
protecting group is removed using 50% piperidine in dimethylformamide (DMF),8-9 
yielding (2). Approximately 3mL of this deprotection solution is used for 10mg of 
intermediate up to about 15mL for 100mg of intermediate. The deprotection proceeds at 
room temperature for approximately 10 minutes before being dried down on a rotovap. 
Completion of the deprotection is confirmed using MALDI TOFMS. 
 After deprotection of the N-terminus of the arginine residue, it is thiolated 
using N-succinimidyl S-Acetylthiopropionate (SATP), yielding product (3). A protected 
thiol is used since any free thiols may interfere with the next reactions, especially 
deprotection of the carboxybenzyl (CBZ) protecting group. The acetyl group may be 
quickly deprotected using hydroxylamine at pH 7.2-7.5.10 The thiolation reaction 
proceeds by dissolving 100mg of the deprotected intermediate in methanol and then 
adding an equal portion of water to bring the solution to 50% methanol. Borate buffer at 
pH 10 is added to increase the total volume by approximately 50-75%. 55mg of SATP is 
dissolved in DMF and the aqueous reaction solution is slowly mixed with the SATP 
solution. After complete mixing, the reaction is allowed to proceed at room temperature 
and constant stirring for 1.5 hours. The progress of the reaction is then checked by 
desalting using ziptips followed by analysis using MALDI TOFMS. 
 After thiolation, the reaction solution is once again dried on a rotovap. The 
remaining solid (ca. 300mg) is separated using a flash column of approximately 0.5 inch 
diameter and a stationary phase length of 5-6 inches.7 The solvent system used is 20% 
methanol in DCM. The second intermediate elutes at roughly two column volumes. 
MALDI TOFMS is used to locate the fractions of interest. Tandem MS analysis  was 
completed to tentatively confirm the structure, however further purification and NMR 
analysis would be required for positive identification.  
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 NMR was attempted on both intermediates; however the purity from the flash 
column was not high enough. Both 1D and 2D NMR experiments resulted in numerous 
peaks that could not be reconciled with the predicted structure. A possible source of 
contaminants (which explain some of the NMR peaks) was found to originate from the 
plastic eppendorf tubes used for sample handling.11 Confirmation experiments were 
conducted whereby several eppendorf tubes were placed in pure high grade methanol. 
After resting overnight, a film was visible on the surface of the methanol, despite the 
container being covered. Further syntheses using only glass culture tubes showed less 
contamination in the NMR spectra, however it was still not possible to unambiguously 
prove the structure of the label using NMR. 
 The mass spectrum of the same sample seemed to indicate that the isolated 
intermediate was relatively pure, aside from a few peaks attributed to the MALDI matrix.  
It is thought that a contaminant is coeluting but since the label intermediates readily 
ionize (due to the arginine group) label signal is swamping contaminant signal, which 
ionizes to a lower degree under any circumstances. The intermediates were analyzed 
using HPLC under isocratic elution to try to increase the purity level, but these efforts 
also failed. 
 The next step in the synthesis (not completed yet) would be to deprotect the 
carboxybenzyl (CBZ) group from the other primary amine site.12-13 Briefly, this is 
accomplished by completely drying down the product and then dissolving in methanol. It 
is important that no water remain since it will not allow the reaction to proceed. After 
dissolving the protected intermediate in methanol, an amount of Pd/C (10%) equal to 
10% of the mass of the intermediate is added to the solution. Care should be exercised 
as this is done since the Pd/C may ignite when added to the methanol solution. The 
headspace is then purged with hydrogen and a septum is used to seal the flask. The 
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hydrogen filled balloon is stretched over the end of a syringe and the needle is pushed 
through the septum to provide a steady hydrogen supply at a partial pressure. The 
reaction proceeds for 1-1.5 hours under constant stirring at room temperature.  
 Upon completion, the Pd/C catalyst is filtered off over a bed of celite 
(diatomaceous earth from Sigma). Reaction progress may be checked using MALDI 
TOFMS. Further care should be taken when filtering since the Pd/C that has been 
exposed to hydrogen may ignite if it dries out. Once done filtering, the entire filtering 
material (including Pd/C) should be sealed in a vial filled with water for disposal. 
  This CBZ deprotection reaction works well – quickly and quantitatively – 
when performed on the first intermediate (1), however efforts to deprotect the second 
intermediate (after thiolation by SATP) have been largely unsuccessful. This is thought 
to be due to the presence of the protected thiol, a small amount of which may be 
deprotected, poisoning the Pd/C catalyst. Reversing the order of deprotection (i.e. 
deprotecting the CBZ group first, followed by FMOC) is not possible since the protected 
thiol (added to the CBZ protected primary amine) deprotects under the deprotection 
conditions required for FMOC (i.e. basic conditions). The acetyl group of the thiol is 
cleaved allowing the free thiol to modify the dibenzofulvene derivative of the FMOC 
deprotection through a Michael addition (Figure A4). Efforts to remove this group from 
the thiol also failed. 
 The addition of the macrocycle would follow CBZ deprotection. The 
macrocycle would be added using an isothiocyanate moiety for the modification of the 
deprotected primary amine.14-15 The reaction conditions required were investigated using 
model peptides. The optimal conditions required mixing the isothiocyanate macrcycle 
and the peptide (a 10:1 molar ratio) at an ammonium bicarbonate buffered pH of 8.6.   
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The reaction was allowed to proceed at 55˚C for 1.5 hours. Reaction progress was 
checked by desalting using a ziptip, and analysis using MALDI TOFMS. 
 Had the synthesis of the shift reagent been completed, it would be used to 
label phosphopeptides for analysis by MALDI-IM-TOFMS. This would be accomplished 
by beta elimination of the phosphate group (as described in Chapter IV)16 under basic 
conditions, followed by addition of the label through Michael addition of the thiol terminus 
to the peptide. Reaction conditions would have to be optimized since the label 
represents a significant increase in mass and size over the ethanedithiol linker currently 
used by groups doing phosphopeptide analysis.  
 Furthermore, this label would eliminate the steps of gel purification to remove 
unreacted ethanedithiol, as well as a labeling reaction to modify the new thiol with a shift 
reagent. The ability to skip these steps through the use of a thiol terminated shift reagent 
would significantly decrease the time commitment required for phosphopeptide specific 
labeling. The addition of a highly basic site (the arginine residue) would also enhance 
ionization of the resulting labeled phosophopeptide, allowing for analysis of less 
abundant phosphoproteins. 
 Enhanced ionization would be beneficial for analysis of smaller sample sizes 
and lower abundance proteins. It would especially aid in the analysis of 
phosphopeptides in biological matrices since phosphorylation can be a time-dependent 
PTM and is not completely stoichiometric, meaning that not all copies of a particular 
protein are phosphorylated at a given time. Additionally, a thiol terminated label such as 
this could also be used labeling of O-linked glycans, since glycans can also undergo 
beta elimination. Some a priori knowledge of the sample is required in order to avoid 
confusion between glycopeptides and phosphopeptides.  
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 Other possibilities exist whereby different functionality could be covalently 
bound to the macrocycle through reaction with the thiol terminus of this tag, or through 
the other moieties mentioned in this report. Oligonucleotide sequences could be used to 
create a DNA sequence probe. A biotin moiety could be inserted in the linker region of 
the label to provide a method of affinity purification prior to IM-MS analysis. Means of 
analysis of other amino acid residues or PTMs could be added to a macrocycle. In short, 
the future of IM-MS shift reagents appears bright, with many different applications surely 
to be developed in the coming years. 
 We are grateful for financial support provided by the Defense Threat 
Reduction Agency (HDTRA1-09-1-0013), the National Institute on Drug Abuse 
(RC2DA028981), the Vanderbilt University College of Arts and Sciences, the Vanderbilt 
Institutes for Chemical Biology, the Vanderbilt Institute for Integrative Biosystems 
Research, and Ionwerks, Inc (Houston, TX). 
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APPENDIX B 
 
MOUSE BRAIN TISSUE LABELING PROGRESS 
 
 The development of mass spectrometric imaging (MSI) methods by the 
Caprioli lab1-2 in the late 1990’s has enabled detailed analysis of intact tissue sections, 
allowing elucidation of the location of specific molecules within tissue sections. 
Biomolecules like lipids and peptides can be highlighted to determine not only their 
location, but also their identity through MS/MS analysis.2,3-4Furthermore, non-natural 
molecules, such as drugs (or their metabolites) may be localized to study the distribution 
kinetics and ultimate fate of drugs as they are metabolized by the body.5  
 Development of on tissue (in situ) reactions has occurred concurrently with 
widespread use of MSI. Trypsin proteolysis has been used to cleave the proteins 
present in tissue sections,6 making analysis and identification by MS methods much 
easier.Current staining and labeling reactions can provide qualitative information about 
the tissue section under study.7-9 DNA labeling, for example, has been used to 
determine if a significant amount of apoptosis has taken place.8 Application of in situ shift 
reagent labeling is proposed in this chapter as a way to extract more information from 
IM-MS spectra of tissue sections. Toward this goal, the cysteine specific label 
(containing a maleimido reactive moiety) and a primary amine label (containing an 
isothiocyanate reactive moiety) were tested for their applicability to in situ tissue labeling. 
 Imaging of tissue sections usually proceeds by flash freezing the extracted 
tissue in liquid nitrogen immediately after dissection. This frozen tissue is sliced on a 
cryostat so to a thickness of 10-15 μm. The frozen tissue sections are thaw mounted 
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onto a chilled MALDI target plate (or glass microscope slide) by allowing it to fall onto the 
plate after slicing.10 The plate (with tissue slice) is subsequently allowed to equilibrate to 
room temperature, thereby mounting the tissue onto the plate. For the mouse brain 
sections described here, mounting was completed by a collaborating lab.   
 MSI analysis methods eventually recognized great potential in the 
development of in situ reactions (e.g. proteolysis using trypsin) that enhance the data 
collected from tissue sections. Using these methods, proteins in tissue sections can be 
proteolyzed on site to avoid losing location information. In situ proteolysis involves 
spotting a tissue section with a trypsin (in a buffer of pH ~8) using a hand-held pipet in a 
low density droplet array, or by using a nanoliter robotic spotter in high density droplet 
array. Proteins in the tissue section are proteolyzed at room temperature (or alternatively 
the sample may be gently heated) for several hours prior to matrix deposition. Matrix 
may be applied using the same method (hand-held pipet or robotic spotter), or by spray 
coating the entire tissue section. Subsequent to matrix deposition, analysis is completed 
on a MALDI based instrument platform.  
 The use of IM-MS for tissue section imaging analysis provides enhanced data 
over one dimensional MS methods.11 MSI allows analysis of the tissue in such a way 
that proteins and other biomolecules are in nearly the same location as they are in vivo.  
IM-MS can separate the biomolecular classes, in addition to chemical noise, in 
conformation space allowing for rapid identification of the class of molecule responsible 
for each signal. In addition, mass spectra of each class may be extracted independently 
for further detailed analysis. This may be useful when only changes specific to the lipid 
profile are sought, rather than the change in expression profile of different classes of 
biomolecules. An example of IM-MS analysis of a mouse brain prior to in situ trypsin 
proteolysis is shown in Figure B1.  
102 
 Typical experiments involving in situ proteolysis of mouse brain samples by 
trypsin proceeded as follows. The brain sections (mounted on a MALDI target plate) 
were stored in the -80˚C freezer until used. The MALDI plate was allowed to equilibrate 
to room temperature in a dessicator prior to manipulation. After the plate warmed to 
room temperature, a 0.5μL aliquot of trypsin solution (2μg/mL in 100mM ammonium 
bicarbonate, pH ~8) was spotted by hand onto a brain tissue section. The spot was 
allowed to react at room temperature until dry. Trypsin was spotted twice more in a 
similar fashion. The brain section was then washed in a cold ethanol solution (75-100%) 
for 20 seconds in an effort to remove some of the high abundance lipid signal (intense 
lipid signals tend to overpower weaker peptide signals) and the salts from the reaction 
buffer. The plate was allowed to dry completely before proceeding. When the plate was 
dry, alpha cyano buffer was spotted by hand over the area in a low density droplet array, 
and allowed to dry. Analysis was completed using MALDI-IM-TOFMS (Waters Synapt 
G2). A typical spectrum of proteolyzed mouse brain is shown in Figure B2.  
 Labeling reactions were attempted using two different shift reagent labels. 
The first label was a thiol specific shift reagent for the selective modification the free thiol 
of cysteine residues via a maleimide moiety. This label was discussed in Chapter III. 
Briefly, labeling reactions proceeded by chelating a lanthanide metal into the macrocycle 
(in a 100:1 ratio and pH 5.7) as described previously.12 The loaded label (100mM, still in 
the pH 5.7 buffered reaction solution) was spotted onto a brain section, both before and 
after proteolysis. The spot was allowed to react at room temperature until dry. An 
additional two aliquots were spotted on the brain section in this manner. Subsequent to 
the labeling reaction, the brain section was washed in cold ethanol (75-100%) in order to 
remove some of the lipids and salts from the reaction mixture.13 Alpha cyano matrix was 
spotted and analysis was completed using MALDI-IM-TOFMS as illustrated in Figure B3. 
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Figure B1. A two dimensional representation of IM-MS conformation space data for an 
unproteolyzed, unlabeled mouse brain tissue section. The brain was flash frozen and a 
12 micron thick section was thaw mounted onto a stainless steel MALDI target plate. 
Alpha cyano matrix was applied by hand in aliquots of 0.6 microliters in a low density 
droplet array. Analysis was performed on a Waters Synapt G2 instrument.  
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Figure B2. A representation of two dimensional IM-MS conformation space for analysis 
of an in situ trypsin proteolyzed, unlabeled mouse brain. The brain was flash frozen and 
a 12 micron thick slice was thaw mounted directly onto a stainless steel MALDI target 
plate. Trypin was applied in a low density droplet array by hand in 0.6 microliter aliquots. 
After digestion, alpha cyano matrix was applied in the same manner. Analysis was 
performed on a Waters Synapt G2 instrument.  
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Primary amine specific on tissue labeling reaction was explored using a shift reagent 
containing an isothiocyanate moiety. Labeling reactions proceeded by chelating a 
lanthanide metal to the macrocycle at pH 5.7 (a 100:1 ratio)12 and then adding 
ammonium bicarbonate buffer to adjust the pH to 8. This loaded label solution was 
spotted onto a brain section both before and after proteolysis. The plate was placed on a 
heating block and heated to 55˚C under an atmosphere of methanol and water. This 
atmosphere was created by placing the MALDI plate on the heat block next to a tube 
filled with 50% methanol and inverting a glass petri dish over both. The reaction was 
allowed to proceed until the spot was dry. The reaction mixture was spotted twice more 
in the same manner. Subsequent to labeling, the brain section was washed in cold 
ethanol (75-100%) for 20 seconds to remove some of the lipids and salts from the 
reaction buffers.13 Alpha cyano matrix was spotted and analysis was completed using 
MALDI-IM-TOFMS. 
 Tandem MS analysis of high intensity signals in the peptide correlation band 
was done to try to identify several of the peptides, and thus proteins, available in the 
mouse brain samples. Signals within the peptide correlation band were selected for CID 
fragmentation in the Waters Synapt G2 instrument. After fragmentation, the resulting 
MS/MS spectra were analyzed for sequence information. Mascot was used to aid in the 
identification of the sequence of peptides analyzed by MS/MS.14 
 The mascot utility was initially allowed to search all categories to try to get the 
best match for some of the short peptides. A second round of analysis was done by 
restricting the search to known mouse proteins. The results of these searches yielded 
several tentative peptide sequence matches, however the scores for these matches was 
low. At a p value of 0.5, a mascot score of 45 would be required for a significant hit. 
Many of the scores analyzed so far have been in the 20s and 30s, and are insignificant.  
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Figure B3. A two dimensional representation of IM-MS conformation space data for a 
section of labeled mouse brain. The brain was flash frozen and a 12 micron thick slice 
was thaw mounted directly onto a stainless steel MALDI target plate. Alpha cyano matrix 
was applied in a low density droplet array by hand in 0.6 microliter aliquots. The labeling 
reaction consisted of a maleimide based shift reagent coordinated to terbium metal. 
Cysteine containing peptides are believed to be labeled and shifted to an area around 
1300-1500 Daltons and about 10ms drift time. Analysis was performed on a Waters 
Synapt G2 instrument.  
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Further analysis and confident identification would require more signal in the MS/MS 
spectrum. More signal could be acquired through optimization of instrument settings and 
wash steps prior to analysis. 
 Further work in this area would involve the optimization of the in situ labeling 
reactions for both the cysteine specific label and the primary amine specific label. 
Instrument settings could possibly be optimized further, however most improvements are 
expected to come from changing reaction conditions. Further MS/MS analysis would be 
completed, including the use of other bioinformatics platforms to aid in the identification 
of peptide signals. The sequence identification of several peptides that are labeled would 
be a critical next piece of data.  
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APPENDIX C 
 
REFERENCES OF ADAPTATION FOR CHAPTERS 
 
Chapter I: Sections adapted from Randi L. Gant-Branum, Thomas J. Kerr, and John A. 
McLean, “Labeling Strategies in Mass Spectrometry-Based Protein Quantitation”, The 
Analyst 2009, 134, 1525-1530. 
Chapter II: Adapted from Thomas J. Kerr and John A. McLean, “Peptide Quantitation 
Using Primary Amine Selective Metal Chelation Labels for Mass Spectrometry”, 
Chemical Communications, 2010, 46, 5479-5481. 
Chapter III: Adapted from Thomas J. Kerr and John A. McLean, “High Density Shift 
Reagents for Multiplexed Peptide Characterization by Ion Mobility-Mass Spectrometry”, 
In preparation for submission to Analytical Chemistry 2011. 
Chapter IV: Adapted from Thomas J. Kerr, Randi L. Gant-Branum, and John A. McLean, 
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